<SEC-DOCUMENT>0001193125-24-241886.txt : 20241023
<SEC-HEADER>0001193125-24-241886.hdr.sgml : 20241023
<ACCEPTANCE-DATETIME>20241023163421
ACCESSION NUMBER:		0001193125-24-241886
CONFORMED SUBMISSION TYPE:	424B7
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20241023
DATE AS OF CHANGE:		20241023

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brookdale Senior Living Inc.
		CENTRAL INDEX KEY:			0001332349
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-NURSING & PERSONAL CARE FACILITIES [8050]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				203068069
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B7
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268404
		FILM NUMBER:		241389580

	BUSINESS ADDRESS:	
		STREET 1:		105 WESTWOOD PLACE
		STREET 2:		SUITE 400
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
		BUSINESS PHONE:		(615) 221-2250

	MAIL ADDRESS:	
		STREET 1:		105 WESTWOOD PLACE
		STREET 2:		SUITE 400
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B7
<SEQUENCE>1
<FILENAME>d869187d424b7.htm
<DESCRIPTION>424B7
<TEXT>
<HTML><HEAD>
<TITLE>424B7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed pursuant to 424(b)(7) <BR> Registration Statement No. 333-268404<BR> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(To Prospectus dated November&nbsp;16, 2022) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g869187g01a01.jpg" ALT="LOGO" STYLE="width:4.16667in;height:0.925692in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>BROOKDALE SENIOR LIVING INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>54,968,244 SHARES OF COMMON STOCK OFFERED BY THE SELLING SECURITYHOLDERS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement relates to the offer and resale from time to time by the Selling Securityholders named in this prospectus
supplement (the &#147;Selling Securityholders&#148;), or their permitted transferees of up to 54,968,244 shares of common stock of the Company, par value $0.01 per share (the &#147;common stock&#148;). All of the shares of common stock being offered
for resale by the Selling Securityholders pursuant to this prospectus supplement are shares of common stock issuable to the Selling Securityholders upon conversion of the Company&#146;s outstanding 3.50% Convertible Senior Notes due 2029 (the
&#147;Notes&#148;) issued by us in a private placement completed on October&nbsp;3, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The conversion rate, and therefore the number
of shares of common stock issuable to the Selling Securityholders upon conversion of the Notes, is subject to adjustment in certain circumstances. Accordingly, the number of shares of common stock issuable with respect to the Notes may increase or
decrease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our registration of the securities covered by this prospectus supplement does not mean that the Selling Securityholders will
offer or sell any of the securities. The Selling Securityholders may offer and sell the securities covered by this prospectus supplement in a number of different ways and at varying prices. We provide more information about how the Selling
Securityholders may sell the shares of common stock in the section entitled &#147;<I>Plan of Distribution</I>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not receive
any proceeds from the sale of shares of common stock by the Selling Securityholders pursuant to this prospectus supplement. However, we will pay the expenses, other than underwriting discounts and commissions, incurred by the Selling Securityholders
in connection with the registration of the securities covered by this prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the New York
Stock Exchange under the trading symbol &#147;BKD.&#148; On October&nbsp;22, 2024, the last reported sale price of our common stock was $6.18 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in our securities involves risks. You should read the section entitled &#147;</B><B><I><A HREF="#suprom869187_5">Risk&nbsp;
Factors</A></I></B><B>&#148; beginning on page <FONT STYLE="white-space:nowrap">S-2</FONT> of this prospectus supplement and in the documents incorporated by reference herein, before buying our securities. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission (the &#147;SEC&#148;) nor any state securities commission has approved or disapproved of
these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus supplement is October&nbsp;23, 2024. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><B>Prospectus Supplement</B></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom869187_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-ii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom869187_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-iii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom869187_3">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-iv</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom869187_4">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom869187_5">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-2</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom869187_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-3</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom869187_7">SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom869187_8">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom869187_9">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-8</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom869187_10">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Prospectus</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_3">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_4">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_5">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_7">DESCRIPTION OF SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_8">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_9">DESCRIPTION OF DEPOSITARY SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_10">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_11">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_12">DESCRIPTION OF SUBSCRIPTION RIGHTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_13">DESCRIPTION OF PURCHASE CONTRACTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_14">DESCRIPTION OF PURCHASE UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_15">SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_16">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_17">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_18">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom869187_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document consists of two parts. The first part is this prospectus supplement, which describes the specific terms of this offering and
also adds to and updates information contained in the accompanying prospectus and the documents incorporated by reference. The second part is the accompanying prospectus, which gives more general information, some of which may not apply to this
offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent there is a conflict between the information contained in this prospectus supplement and the information contained
in the accompanying prospectus or any document incorporated by reference therein filed prior to the date of this prospectus supplement, you should rely on the information in this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless we specifically state otherwise, the information in this prospectus supplement and the accompanying prospectus, including the documents
incorporated by reference herein and therein, does not give effect to the transactions contemplated herein. You should rely only on the information contained or incorporated by reference in this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor the Selling Securityholders have authorized anyone to provide you with any information other than that contained in or
incorporated by reference into this prospectus supplement and the accompanying prospectus prepared by or on behalf of us. Neither we nor the Selling Securityholders take responsibility for, and can provide no assurance as to the reliability of, any
other information that others may give you. Neither we nor the Selling Securityholders are making an offer to sell these securities in any jurisdiction where the offer or sale is not authorized or in which the person making such offer or
solicitation is not qualified to do so or to anyone to whom it is unlawful to make an offer or solicitation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom869187_2"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC under the Securities Exchange Act of 1934,
as amended (the &#147;Exchange Act&#148;). Our SEC filings are available to the public at the SEC&#146;s website at www.sec.gov. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC
allows us to &#147;incorporate by reference&#148; information into this prospectus supplement and any accompanying prospectus, which means that we can disclose important information to you by referring you to another document filed separately with
the SEC. The information incorporated by reference is deemed to be part of this prospectus supplement and the accompanying prospectus, except for any information superseded by information contained in any subsequently filed document deemed
incorporated by reference or any free writing prospectus prepared by or on behalf of us. This prospectus supplement and the accompanying prospectus incorporate by reference the documents set forth below that we have previously filed with the SEC
(other than information deemed furnished and not filed in accordance with SEC rules, including Items 2.02 and 7.01 of <FONT STYLE="white-space:nowrap">Form&nbsp;8-K):</FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234922000043/bkd-20211231.htm">our
 Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December<U></U>&nbsp;31, 2023, filed with the SEC on February<U></U>&nbsp;21, 2024</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the information specifically incorporated by reference into our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;
31, 2023 from <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000119312524122392/d413524ddef14a.htm">our definitive proxy statement on Schedule 14A, filed with the SEC on April<U></U>&nbsp;29, 2024</A>;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the fiscal quarters ended <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234924000078/bkd-20240331.htm">March
<U></U>&nbsp;31, 2024</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234924000102/bkd-20240630.htm">June<U></U>&nbsp;30, 2024</A>, filed with the SEC on May&nbsp;8, 2024 and August&nbsp;9,
2024, respectively; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234924000069/bkd-20240326.htm">April
<U></U>&nbsp;1, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234924000084/bkd-20240618.htm">June<U></U>&nbsp;
20, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234924000111/bkd-20240930.htm">September<U></U>&nbsp;
30, 2024</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234924000114/bkd-20241003.htm">October<U></U>&nbsp;4, 2024</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our common stock contained in our <A HREF="http://www.sec.gov/Archives/edgar/data/1332349/000095012305012036/y13516e8va12b.htm">Registration
 Statement on Form <FONT STYLE="white-space:nowrap">8-A</FONT></A>, filed with the SEC on October&nbsp;
11, 2005, and any amendment or report filed for the purpose of updating such description (including <A HREF="http://www.sec.gov/Archives/edgar/data/1332349/000133234923000075/descriptionofsecurities.htm">Exhibit 4.2</A> to the Quarterly Report on
Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the fiscal quarter ended March&nbsp;31, 2023 filed with the SEC on May&nbsp;9, 2023). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All documents filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus supplement and
before the termination of the offering also shall be deemed to be incorporated herein by reference. We are not, however, incorporating by reference any documents or portions thereof that are not deemed &#147;filed&#148; with the SEC, including any
information furnished pursuant to Items 2.02 or 7.01 of <FONT STYLE="white-space:nowrap">Form&nbsp;8-K.</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If requested, we will
provide to each person, including any beneficial owner, to whom a prospectus is delivered, a copy of any or all of the information that has been incorporated by reference in the prospectus but not delivered with the prospectus. Exhibits to the
filings will not be sent, however, unless those exhibits have specifically been incorporated by reference into such documents. To obtain a copy of these filings at no cost, you may write or telephone us at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Brookdale Senior Living Inc., Attn: Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 Westwood Place, Suite 400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Brentwood, Tennessee 37027 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(615) <FONT
STYLE="white-space:nowrap">221-2250</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom869187_3"></A>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain statements in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference may
constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to various risks and uncertainties and include all statements that are not historical
statements of fact and those regarding our intent, belief or expectations. Forward-looking statements are generally identifiable by use of forward-looking terminology such as &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;could,&#148;
&#147;would,&#148; &#147;potential,&#148; &#147;intend,&#148; &#147;expect,&#148; &#147;endeavor,&#148; &#147;seek,&#148; &#147;anticipate,&#148; &#147;estimate,&#148; &#147;believe,&#148; &#147;project,&#148; &#147;predict,&#148;
&#147;continue,&#148; &#147;plan,&#148; &#147;target,&#148; or other similar words or expressions. These forward-looking statements are based on certain assumptions and expectations, and our ability to predict results or the actual effect of future
plans or strategies is inherently uncertain. Although we believe that expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our assumptions or expectations will be attained, and
actual results and performance could differ materially from those projected. Factors which could have a material adverse effect on our operations and future prospects or which could cause events or circumstances to differ from the forward-looking
statements include, but are not limited to, events which adversely affect the ability of seniors to afford resident fees, including downturns in the economy, housing market, consumer confidence, or the equity markets and unemployment among resident
family members; changes in reimbursement rates, methods, or timing under governmental reimbursement programs including the Medicare and Medicaid programs; the effects of senior housing construction and development, lower industry occupancy, and
increased competition; conditions of housing markets, regulatory changes, acts of nature, and the effects of climate change in geographic areas where we are concentrated; terminations of our resident agreements and vacancies in the living spaces we
lease; failure to maintain the security and functionality of our information systems, to prevent a cybersecurity attack or breach, or to comply with applicable privacy and consumer protection laws, including HIPAA; our ability to complete our
capital expenditures in accordance with our plans; our ability to identify and pursue development, investment, and acquisition opportunities and our ability to successfully integrate acquisitions; competition for the acquisition of assets; our
ability to complete pending or expected disposition, acquisition, or other transactions on agreed upon terms or at all, including in respect of the satisfaction of closing conditions, the risk that regulatory approvals are not obtained or are
subject to unanticipated conditions, and uncertainties as to the timing of closing, and our ability to identify and pursue any such opportunities in the future; risks related to the implementation of our strategy, including initiatives undertaken to
execute on our strategic priorities and their effect on our results; the impacts of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, including on the nation&#146;s economy and debt and equity markets and the local economies in our
markets, and on us and our business, results of operations, cash flow, revenue, expenses, liquidity, and our strategic initiatives, including plans for future growth, which will depend on many factors, some of which cannot be foreseen, including the
pace and consistency of recovery from the pandemic and any resurgence or variants of the disease; limits on our ability to use net operating loss carryovers to reduce future tax payments; delays in obtaining regulatory approvals; disruptions in the
financial markets or decreases in the appraised values or performance of our communities that affect our ability to obtain financing or extend or refinance debt as it matures and our financing costs; our ability to generate sufficient cash flow to
cover required interest, principal, and long-term lease payments and to fund our planned capital projects; the effect of any <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any of our debt or lease agreements (including the financial or
other covenants contained therein), including the risk of lenders or lessors declaring a cross default in the event of our <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any such agreements and the risk of loss of our property securing
leases and indebtedness due to any resulting lease terminations and foreclosure actions; the inability to renew, restructure, or extend leases, or exercise purchase options at or prior to the end of any existing lease term; the effect of our
indebtedness and long-term leases on our liquidity and our ability to operate our business; increases in market interest rates that increase the costs of our debt obligations; our ability to obtain additional capital on terms acceptable to us;
departures of key officers and potential disruption caused by changes in management; increased competition for, or a shortage of, associates, wage pressures resulting from increased competition, low unemployment levels, minimum wage increases and
changes in overtime laws, and union activity; environmental contamination at any of our communities; failure to comply with existing environmental laws; an adverse determination or resolution of complaints filed against us, including putative class
action complaints and the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
frequency and magnitude of legal actions and liability claims that may arise due to <FONT STYLE="white-space:nowrap">COVID-19</FONT> or our response efforts; negative publicity with respect to
any lawsuits, claims, or other legal or regulatory proceedings; costs to respond to, and adverse determinations resulting from, government inquiries, reviews, audits and investigations; the cost and difficulty of complying with increasing and
evolving regulation, including new disclosure obligations; changes in, or our failure to comply with, employment-related laws and regulations; the risks associated with current global economic conditions and general economic factors on us and our
business partners such as inflation, commodity costs, fuel and other energy costs, competition in the labor market, costs of salaries, wages, benefits, and insurance, interest rates, tax rates, geopolitical tensions or conflicts, and uncertainty
surrounding federal elections; the impact of seasonal contagious illness or an outbreak of <FONT STYLE="white-space:nowrap">COVID-19</FONT> or other contagious disease in the markets in which we operate; actions of activist stockholders, including a
proxy contest; as well as other risks detailed from time to time in our filings with the SEC, including those set forth under &#147;<I>Risk Factors</I>&#148; included elsewhere in this prospectus supplement, the accompanying prospectus and in the
documents incorporated by reference in this prospectus supplement and the accompanying prospectus. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements in such SEC filings and this
prospectus supplement. Readers are cautioned not to place undue reliance on any of these forward-looking statements, which reflect management&#146;s views as of the date of this prospectus supplement. We cannot guarantee future results, levels of
activity, performance or achievements, and, except as required by law, we expressly disclaim any obligation to release publicly any updates or revisions to any forward-looking statements contained in this prospectus supplement to reflect any change
in our expectations with regard thereto or change in events, conditions or circumstances on which any statement is based. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom869187_4"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This is only a summary and may not contain all the information that is important to you. You should carefully read both this prospectus
supplement and any accompanying prospectus, together with the additional information described under the heading &#147;<I>Where You Can Find More Information</I>.&#148; Except as otherwise indicated herein or as the context otherwise requires,
references in this prospectus supplement to &#147;Brookdale,&#148; &#147;the Company,&#148; &#147;we,&#148; &#147;us,&#148; and &#147;our&#148; refer to Brookdale Senior Living Inc. and its consolidated subsidiaries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Brookdale Senior Living Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are the
nation&#146;s premier operator of senior living communities, operating and managing 648 communities in 41 states as of September&nbsp;30, 2024, with the ability to serve approximately 58,000 residents. We offer our residents access to a broad
continuum of services across the most attractive sectors of the senior living industry. We operate and manage independent living, assisted living, memory care, and continuing care retirement communities. As of September&nbsp;30, 2024, we owned 342
communities (30,977 units), leased 277&nbsp;communities (19,860 units), and managed 29 communities (4,362 units). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our senior living
communities and our comprehensive network help to provide seniors with care, connection, and services in an environment that feels like home. Our expertise in healthcare, hospitality, and real estate provides residents with opportunities to improve
wellness, pursue passions, make new friends, and stay connected with loved ones. By providing residents with a range of service options as their needs change, we provide greater continuity of care, enabling seniors to
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">age-in-place,</FONT></FONT> which we believe enables them to maintain residency with us for a longer period of time. The ability of residents to <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">age-in-place</FONT></FONT> is also beneficial to our residents&#146; families who are concerned with care decisions for their elderly relatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive offices are located at 105 Westwood Place, Suite 400, Brentwood, Tennessee 37027 and our telephone number at that
address is (615) <FONT STYLE="white-space:nowrap">221-2250.</FONT> Our website address is www.brookdale.com. The information on, or accessible through, our website is not part of this prospectus supplement or the accompanying prospectus and should
not be relied upon in connection with making any investment decision with respect to the securities offered by this prospectus supplement or the accompanying prospectus. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom869187_5"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should consider the specific risks described in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT>
(together with any material changes thereto contained in subsequently filed Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q)</FONT> and any risk factors set forth in our other filings with the SEC, before making an investment
decision. Each of the risks described in these documents could materially and adversely affect our business, financial condition, results of operations and prospects, and could result in a partial or complete loss of your investment. See
&#147;<I>Where You Can Find More Information</I>&#148; in this prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom869187_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of the shares of common stock offered by the Selling Securityholders pursuant to this prospectus supplement will be sold by the Selling
Securityholders for their respective accounts. We will not receive any of the proceeds from these sales. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom869187_7"></A>SELLING SECURITYHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement relates to the resale by the Selling Securityholders from time to time of up to 54,968,244 shares of our common
stock, issuable by us upon conversion of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;30, 2024, we entered into exchange and subscription agreements with
certain investors, pursuant to which we agreed to sell the Notes pursuant to the terms of an indenture between us and Equiniti Trust Company, LLC, dated as of October&nbsp;3, 2024. The Notes were initially convertible into a maximum of 54,968,244
shares of common stock and were issued in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). Upon conversion of any Notes, we will be obligated to settle such
conversion by paying or delivering, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock, at our election. We will not be obligated to deliver any shares of common stock to any holder upon any
conversion of the Notes to the extent that immediately following such conversion such holder would beneficially own a number of shares of our common stock in excess of 19.9% of the total number of shares of our common stock issued and outstanding
immediately following such conversion. In addition, we entered into a registration rights agreement with certain investors, dated October&nbsp;3, 2024, pursuant to which we agreed to use commercially reasonable efforts to file a prospectus
supplement or shelf registration statement with the SEC on or prior to October&nbsp;25, 2024, providing for the registration and sale of the shares of common stock issuable upon conversion of the Notes. We have agreed with the Selling
Securityholders to use commercially reasonable efforts to cause the registration statement of which this prospectus supplement constitutes a part to become effective and to remain continuously effective until the earlier of (1)&nbsp;the date on
which all of the shares included in the registration statement have been sold pursuant to such registration statement or pursuant to Rule 144 of the Securities Act, (2)&nbsp;the date upon which there are no Notes or shares issued upon conversion of
the Notes held by investors or (3)&nbsp;the date on which all of the shares included in such registration statement may be immediately sold to the public without registration or restriction (including without limitation as to volume by each holder
thereof), and without compliance with any current public information requirement pursuant to Rule 144 of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial
ownership is determined in accordance with the rules of the SEC and accordingly, the number of shares of common stock beneficially owned by each Selling Securityholder in this section does not include the shares of our common stock issuable upon
conversion of the Notes. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to such securities, including the right to acquire such voting or
investment power within 60 days of the date of determination through the exercise of any option, warrant or other right. Except as otherwise indicated, all persons listed below have sole voting and investment power with respect to the shares
beneficially owned by them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in the below table (other than the percentages of our outstanding common stock beneficially
owned) in respect of each Selling Securityholder was furnished by or on behalf of such Selling Securityholder and is as of October&nbsp;15, 2024. Except as may be noted in this section, no Selling Securityholder has, or has had within the past three
years, any material relationship with us or any of our affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will supplement or amend this prospectus supplement if applicable
to include additional Selling Securityholders upon provision of all required information to us and subject to the terms of any relevant agreement between us and the Selling Securityholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Securityholders are not obligated to sell any of the shares of common stock offered by this prospectus supplement. Because the
Selling Securityholders identified in the table may sell some or all of the shares of common stock owned by it that are included in this prospectus supplement, and because there are currently no agreements, arrangements or understandings with
respect to the sale of any such shares of common stock, no estimate can be given as to the number of shares covered by this prospectus supplement that will be held by the Selling Securityholders upon termination of this offering. Therefore, for the
purposes of the following table we have assumed that the Selling Securityholders will sell all of the shares of common stock beneficially </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
owned by it that are covered by this prospectus supplement, but will not sell any other shares of common stock that they may currently own. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Ownership Before Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Securities<BR>Offered&nbsp;by&nbsp;this<BR>Prospectus<BR>Supplement</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Ownership After Offering<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Selling Securityholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>common&nbsp;stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;of&nbsp;common<BR>stock<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>common&nbsp;stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>common&nbsp;stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;of&nbsp;common<BR>stock<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BlackRock, Inc.<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,167,792</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,422,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,167,792</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deerfield Partners, L.P.<SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,612,264</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,660,192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,612,264</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Flat Footed LLC<SUP STYLE="font-size:75%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,004,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,885,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,004,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Assumes the sale of all shares of common stock covered by this prospectus supplement by the Selling
Securityholders and that the Selling Securityholders do not acquire any additional shares of common stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Percentages calculated based upon 199,212,529 shares of common stock issued and outstanding as of October 15,
2024 and excludes restricted stock units and restricted shares and shares of common stock reserved for issuance under our stock incentive plan and purchase plans, outstanding warrants, outstanding convertible senior notes and outstanding tangible
equity units. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The registered holders of the referenced shares beneficially owned, and the referenced shares to be registered,
are the following funds and accounts under management by subsidiaries of BlackRock, Inc.: BlackRock Event Driven Equity Fund, a series of BlackRock Large Cap Series Funds, Inc., BlackRock Strategic Funds &#150; BlackRock Global Event Driven Fund and
Global Event Partners Master Ltd. BlackRock, Inc. is the ultimate parent holding company of such subsidiaries. The number of shares beneficially owned by BlackRock, Inc. does not include shares underlying an aggregate of 336,000 units of our 7.00%
Tangible Equity Units held by such funds and accounts or shares of our common stock held by other funds or accounts affiliated with BlackRock, Inc. On behalf of such subsidiaries, the applicable portfolio managers, as managing directors (or in other
capacities) of such entities, and/or the applicable investment committee members of such funds and accounts, have voting and investment power over the shares held by the funds and accounts which are the registered holders of the referenced shares.
Such portfolio managers and/or investment committee members expressly disclaim beneficial ownership of all shares held by such funds and accounts. The address of such funds and accounts, such subsidiaries and such portfolio managers and/or
investment committee members is 50 Hudson Yards, New York, NY 10001. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Deerfield Partners, L.P. may be deemed to share voting and dispositive power with respect to the shares
reported in the table above. Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P. James E. Flynn is the sole member of the general partner of
each of Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and Mr.&nbsp;Flynn may be deemed to beneficially own the securities of the Company beneficially owned by Deerfield Partners,
L.P. The address of the principal business office of Deerfield Partners, L.P. is 345 Park Avenue South, 12th Floor, New York, NY 10010. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The registered holders of the shares disclosed as being beneficially owned by Flat Footed LLC are FF Hybrid LP
and GP Recovery Fund LLC. The number of shares beneficially owned by Flat Footed LLC does not include shares underlying an aggregate of 336,378 units of our 7.00% Tangible Equity Units held by FF Hybrid LP, Flat Footed Series LLC &#150; Fund 1 and
GP Recovery Fund LLC. The registered holders of the referenced shares to be registered are the following funds and accounts under management by subsidiaries of Flat Footed LLC: FF Hybrid LP, Flat Footed Series LLC &#150; Fund 1 and GP Recovery Fund
LLC. Flat Footed LLC is the investment manager of such subsidiaries. On behalf of such subsidiaries, the applicable portfolio managers, as managing directors (or in other capacities) of such entities, and/or the applicable investment committee
members of such funds and accounts, have voting and investment power over the shares held by the funds and accounts which are the registered holders of the referenced shares. Such portfolio managers and/or investment committee members expressly
disclaim beneficial ownership of all shares held by such funds and accounts. The address of such funds and accounts, such subsidiaries and such portfolio managers and/or investment committee members is 3415 North Pines Way, Suite 205, Wilson, WY,
83014. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom869187_8"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Securityholders, which as used herein includes donees, pledgees, transferees or other <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> selling shares of common stock or interests in shares of common stock received after the date of this prospectus supplement from a Selling Securityholder as a gift, pledge, partnership
distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares of common stock or interests in shares of common stock on any stock exchange, market or trading facility on which the shares
are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated
prices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Securityholders may use any one or more of the following methods when disposing of shares or interests therein: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a
portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">short sales effected after the date the registration statement of which this prospectus supplement is a part is
declared effective by the SEC; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange
or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">broker-dealers may agree with the Selling Securityholders to sell a specified number of such shares at a
stipulated price per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods of sale; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other method permitted by applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Securityholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by
them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock, from time to time, under this prospectus supplement, or under an amendment to this prospectus
supplement under Rule 424(b)(3) or other applicable provision of the Securities Act, amending the list of Selling Securityholders to include the pledgee, transferee or other successors in interest as Selling Securityholders under this prospectus
supplement. The Selling Securityholders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this
prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the sale of our common stock or interests therein, the Selling Securityholders may enter into
hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The Selling Securityholders may also sell shares of our common
stock short and deliver these securities to close out their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The Selling Securityholders may also enter into option or other transactions
with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus supplement, which shares
such broker-dealer or other financial institution may resell pursuant to this prospectus supplement (as supplemented or amended to reflect such transaction). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Securityholders may engage brokers and dealers, and any brokers or dealers may arrange for other brokers or dealers to participate
in effecting sales of our common stock or interests therein. These brokers, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
dealers or underwriters may act as principals, or as an agent of a Selling Securityholder. Broker-dealers may agree with a Selling Securityholder to sell a specified number of the shares at a
stipulated price per share. If the broker-dealer is unable to sell the shares acting as agent for a Selling Securityholder, it may purchase as principal any unsold shares at the stipulated price. Broker-dealers who acquire the shares as principals
may thereafter resell the shares from time to time in transactions in any stock exchange, market or trading facility on which the shares are then listed or traded, at prices and on terms then prevailing at the time of sale, at prices related to the
then-current market price or in negotiated transactions. Broker-dealers may use block transactions and sales to and through broker-dealers, including transactions of the nature described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate proceeds to the Selling Securityholders from the sale of the common stock offered by them will be the purchase price of the
common stock less discounts or commissions, if any. Each of the Selling Securityholders reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made
directly or through agents. We will not receive any of the proceeds from this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Securityholders also may resell all
or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided that they meet the criteria and conform to the requirements of that rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests therein may be
&#147;underwriters&#148; within the meaning of Section&nbsp;2(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn on any resale of the shares may be underwriting discounts and commissions under the Securities Act.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent required, the shares of our common stock to be sold, the names of the Selling Securityholders, the respective purchase
prices and public offering prices, the names of any agents, dealer or underwriter, and any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a
post-effective amendment to the registration statement that includes this prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to comply with the securities
laws of some states, if applicable, the common stock may be sold in these jurisdictions only through registered or licensed brokers or dealers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have advised the Selling Securityholders that the anti-manipulation rules of Regulation M under the Exchange Act, may apply to sales of
shares in the market and to the activities of the Selling Securityholders and their affiliates. In addition, to the extent applicable, we will make copies of this prospectus supplement (as it may be supplemented or amended from time to time)
available to the Selling Securityholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The Selling Securityholders may indemnify any broker-dealer that participates in transactions involving the sale of
the shares against certain liabilities, including liabilities arising under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to indemnify the Selling
Securityholders against liabilities, including liabilities under the Securities Act and state securities laws, relating to the registration of the shares offered by this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed with the Selling Securityholders to use commercially reasonable efforts to cause the registration statement of which this
prospectus supplement constitutes a part to become effective and to remain continuously effective until the earlier of (1)&nbsp;the date on which all of the shares included in the registration statement have been sold pursuant to such registration
statement or pursuant to Rule 144 of the Securities Act, (2)&nbsp;the date upon which there are no Notes or shares issued upon conversion of the Notes held by investors or (3)&nbsp;the date on which all of the shares included in such registration
statement may be immediately sold to the public without registration or restriction (including without limitation as to volume by each holder thereof), and without compliance with any current public information requirement pursuant to Rule 144 of
the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom869187_9"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the issuance of the shares of common stock offered hereby will be passed upon by Skadden, Arps, Slate, Meagher&nbsp;&amp;
Flom, New York, New York. Any underwriters will be advised about legal matters by their own counsel, which will be named in a prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom869187_10"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Brookdale Senior Living Inc. appearing in Brookdale Senior Living Inc.&#146;s Annual Report (Form <FONT
STYLE="white-space:nowrap">10-K)</FONT> for the year ended December&nbsp;31, 2023 and the effectiveness of Brookdale Senior Living Inc.&#146;s internal control over financial reporting as of December&nbsp;31, 2023, have been audited by
Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in
reliance upon such reports given on the authority of such firm as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospectus </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g869187g01p02.jpg" ALT="LOGO" STYLE="width:3.15416in;height:0.706192in;">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>BROOKDALE SENIOR LIVING INC. </B></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Preferred
Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Depositary Shares </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Debt Securities </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Warrants
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Subscription Rights </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Purchase Contracts </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>and
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Purchase Units </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may offer,
issue and sell, together or separately: </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">shares of our common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">shares of our preferred stock, which may be issued in one or more series; </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">depositary receipts, representing fractional shares of our preferred stock, which are called depositary shares;
</P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">debt securities, which may be issued in one or more series, secured or unsecured, convertible and senior,
subordinated or junior subordinated debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">warrants to purchase shares of our common stock, shares of our preferred stock or our debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subscription rights to purchase shares of our common stock, shares of our preferred stock or our debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchase contracts to purchase shares of our common stock, shares of our preferred stock or our debt securities;
and </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchase units, each representing ownership of a purchase contract and debt securities, preferred securities or
debt obligations of <FONT STYLE="white-space:nowrap">third-parties,</FONT> including U.S. treasury securities, or any combination of the foregoing, securing the holder&#146;s obligation to purchase our common stock or other securities under the
purchase contracts. </P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide the specific prices and terms of these securities in one or more supplements to this
prospectus at the time of offering. You should read this prospectus and the accompanying prospectus supplement carefully before you make your investment decision. </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>This prospectus may not be used to sell securities unless accompanied by a prospectus supplement. </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in our securities involves a number of risks. See &#147;</B><B><I><A HREF="#toc869187_5">Risk Factors</A></I></B><B>&#148; on
page&nbsp;6 before you make your investment decision. </B></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may offer securities through underwriting syndicates managed or <FONT
STYLE="white-space:nowrap">co-managed</FONT> by one or more underwriters or dealers, through agents or directly to purchasers, on a continuous or delayed basis. These securities also may be sold by selling securityholders. If required, the
prospectus supplement for each offering of securities will describe the plan of distribution for that offering. For general information about the distribution of securities offered, please see &#147;<I>Plan of Distribution</I>&#148; in this
prospectus. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the New York Stock Exchange (the &#147;<B>NYSE</B>&#148;) under the trading symbol
&#147;BKD.&#148; Each prospectus supplement will indicate whether the securities offered thereby will be listed on any securities exchange. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus or any accompanying prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of
this prospectus is November 16, 2022. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_3">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_4">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_5">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_7">DESCRIPTION OF SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_8">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_9">DESCRIPTION OF DEPOSITARY SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_10">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_11">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_12">DESCRIPTION OF SUBSCRIPTION RIGHTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_13">DESCRIPTION OF PURCHASE CONTRACTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_14">DESCRIPTION OF PURCHASE UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_15">SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_16">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_17">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc869187_18">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of an &#147;automatic shelf&#148; registration statement that we filed with the Securities and Exchange Commission
(the &#147;<B>SEC</B>&#148;) as a &#147;well-known seasoned issuer&#148; as defined in Rule 405 under the Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;), using a &#147;shelf&#148; registration process. Under this process,
we and selling securityholders may sell from time to time any combination of the securities described in this prospectus. This prospectus only provides you with a general description of the securities that we may offer. Each time we or selling
securityholders sell securities, we will provide a supplement to this prospectus that contains specific information about the terms of that offering, including the specific amounts, prices and terms of the securities offered. The prospectus
supplement may also add, update or change information contained in this prospectus. You should carefully read both this prospectus, any accompanying prospectus supplement and any free writing prospectus prepared by or on behalf of us, together with
the additional information described under the heading &#147;<I>Where You Can Find More Information</I>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not authorized
anyone to provide you with any information other than that contained in or incorporated by reference into this prospectus, any accompanying prospectus supplement and any free writing prospectus prepared by or on behalf of us. We take no
responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We are not making offers to sell the securities in any jurisdiction in which an offer or solicitation is not authorized or in
which the person making such offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make an offer or solicitation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in this prospectus is accurate as of the date on the front cover. You should not assume that the information contained in this
prospectus is accurate as of any other date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When used in this prospectus, the terms &#147;<B>Brookdale</B>,&#148; the
&#147;<B>Company</B>,&#148; &#147;we,&#148; &#147;our&#148; and &#147;us&#148; refer to Brookdale Senior Living Inc. and its consolidated subsidiaries, unless otherwise specified or the context otherwise requires. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_2"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC under the Securities Exchange Act of 1934,
as amended (the &#147;<B>Exchange Act</B>&#148;). Our SEC filings are available to the public at the SEC&#146;s website at www.sec.gov. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; information into this prospectus and any accompanying prospectus supplement, which
means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus and any accompanying prospectus supplement,
except for any information superseded by information contained directly in this prospectus, any accompanying prospectus supplement, any subsequently filed document deemed incorporated by reference or any free writing prospectus prepared by or on
behalf of us. This prospectus and any accompanying prospectus supplement incorporate by reference the documents set forth below that we have previously filed with the SEC (other than information deemed furnished and not filed in accordance with SEC
rules, including Items 2.02 and 7.01 of Form <FONT STYLE="white-space:nowrap">8-K).</FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234922000043/bkd-20211231.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended December&nbsp;31, 2021, filed with the SEC on February&nbsp;15, 2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the information specifically incorporated by reference into our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021 from our <A HREF="http://www.sec.gov/Archives/edgar/data/1332349/000119312522136855/d261794ddef14a.htm">definitive proxy statement</A> on Schedule 14A, filed
with the SEC on May&nbsp;2, 2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the fiscal quarters ended
March&nbsp;31, 2022, June&nbsp;30, 2022 and September&nbsp;30, 2022, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234922000061/bkd-20220331.htm">May&nbsp;
6, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234922000073/bkd-20220630.htm">August&nbsp;
9, 2022</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234922000082/bkd-20220930.htm">November<B>&nbsp;</B>8, 2022</A>, respectively; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234922000065/bkd-20220621.htm">June&nbsp;21,
 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234922000068/bkd-20220729.htm">August&nbsp;
1, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234922000074/bkd-20220804.htm">August&nbsp;
9, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1332349/000133234922000076/bkd-20221003.htm">and October&nbsp;6, 2022</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our common stock contained in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1332349/000095012305012036/y13516e8va12b.htm">Form
 <FONT STYLE="white-space:nowrap">8-A</FONT></A>, filed with the SEC on October&nbsp;11, 2005, and any amendment or report filed for the purpose of updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All documents filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus and before the
termination of the offering also shall be deemed to be incorporated herein by reference. We are not, however, incorporating by reference any documents or portions thereof that are not deemed &#147;filed&#148; with the SEC, including any information
furnished pursuant to Items 2.02 or 7.01 of Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If requested, we will provide to each
person, including any beneficial owner, to whom a prospectus is delivered, a copy of any or all of the information that has been incorporated by reference in the prospectus but not delivered with the prospectus. Exhibits to the filings will not be
sent, however, unless those exhibits have specifically been incorporated by reference into such documents. To obtain a copy of these filings at no cost, you may write or telephone us at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Brookdale Senior Living Inc., Attn: Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 Westwood Place, Suite 400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Brentwood, Tennessee 37027 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(615) <FONT
STYLE="white-space:nowrap">221-2250</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_3"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain statements in this prospectus, any accompanying prospectus supplements and the documents incorporated by reference may constitute
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to various risks and uncertainties and include all statements that are not historical statements of
fact and those regarding our intent, belief or expectations. <FONT STYLE="white-space:nowrap">Forward-looking</FONT> statements are generally identifiable by use of forward-looking terminology such as &#147;may,&#148; &#147;will,&#148;
&#147;should,&#148; &#147;could,&#148; &#147;would,&#148; &#147;potential,&#148; &#147;intend,&#148; &#147;expect,&#148; &#147;endeavor,&#148; &#147;seek,&#148; &#147;anticipate,&#148; &#147;estimate,&#148; &#147;believe,&#148; &#147;project,&#148;
&#147;predict,&#148; &#147;continue,&#148; &#147;plan,&#148; &#147;target,&#148; or other similar words or expressions. These forward-looking statements are based on certain assumptions and expectations, and our ability to predict results or the
actual effect of future plans or strategies is inherently uncertain. Although we believe that expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our assumptions or expectations
will be attained, and actual results and performance could differ materially from those projected. Factors which could have a material adverse effect on our operations and future prospects or which could cause events or circumstances to differ from
the forward-looking statements include, but are not limited to, the impacts of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, including the response efforts of federal, state, and local government authorities, businesses,
individuals, and us on our business, results of operations, cash flow, revenue, expenses, liquidity, and our strategic initiatives, including plans for future growth, which will depend on many factors, some of which cannot be foreseen, including the
duration, severity, and breadth of the pandemic and any resurgence or variants of the disease, the impact of <FONT STYLE="white-space:nowrap">COVID-19</FONT> on the nation&#146;s economy and debt and equity markets and the local economies in our
markets, the development, availability, utilization, and efficacy of <FONT STYLE="white-space:nowrap">COVID-19</FONT> testing, therapeutic agents, and vaccines and the prioritization of such resources among businesses and demographic groups,
government financial and regulatory relief efforts that may become available to business and individuals, including our ability to qualify for and satisfy the terms and conditions of financial relief, perceptions regarding the safety of senior
living communities during and after the pandemic, changes in demand for senior living communities and our ability to adapt our sales and marketing efforts to meet that demand, the impact of <FONT STYLE="white-space:nowrap">COVID-19</FONT> on our
residents&#146; and their families&#146; ability to afford our resident fees, including due to changes in unemployment rates, consumer confidence, housing markets, and equity markets caused by <FONT STYLE="white-space:nowrap">COVID-19,</FONT>
changes in the acuity levels of our new residents, the disproportionate impact of <FONT STYLE="white-space:nowrap">COVID-19</FONT> on seniors generally and those residing in our communities, the duration and costs of our response efforts, including
increased equipment, supplies, labor, litigation, testing, vaccination clinic, health plan, and other expenses, greater use of contract labor and overtime due to <FONT STYLE="white-space:nowrap">COVID-19</FONT> and general labor market conditions,
the impact of <FONT STYLE="white-space:nowrap">COVID-19</FONT> on our ability to complete financings and refinancings of various assets, or other transactions or to generate sufficient cash flow to cover required debt, interest, and lease payments
and to satisfy financial and other covenants in our debt and lease documents, increased regulatory requirements, including the costs of unfunded, mandatory testing of residents and associates and provision of test kits to our health plan
participants, increased enforcement actions resulting from <FONT STYLE="white-space:nowrap">COVID-19,</FONT> government action that may limit our collection or discharge efforts for delinquent accounts, and the frequency and magnitude of legal
actions and liability claims that may arise due to <FONT STYLE="white-space:nowrap">COVID-19</FONT> or our response efforts; events which adversely affect the ability of seniors to afford resident fees, including downturns in the economy, housing
market, consumer confidence, or the equity markets and unemployment among resident family members; changes in reimbursement rates, methods, or timing under governmental reimbursement programs including the Medicare and Medicaid programs; the effects
of senior housing construction and development, lower industry occupancy (including due to the pandemic), and increased competition; conditions of housing markets, regulatory changes, acts of nature, and the effects of climate change in geographic
areas where we are concentrated; terminations of our resident agreements and vacancies in the living spaces we lease, including due to the pandemic; failure to maintain the security and functionality of our information systems, to prevent a
cybersecurity attack or breach, or to comply with applicable privacy and consumer protection laws, including HIPAA; our ability to complete our capital expenditures in accordance with our plans; our ability to identify and pursue development,
investment, and acquisition opportunities and our ability to successfully integrate acquisitions; competition for the acquisition of assets; our ability to complete pending or expected disposition, acquisition, or other transactions on agreed upon
terms or at all, including in respect of the satisfaction of closing conditions, the risk that regulatory approvals are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not obtained or are subject to unanticipated conditions, and uncertainties as to the timing of closing, and our ability to identify and pursue any such opportunities in the future; risks related
to the implementation of our strategy, including initiatives undertaken to execute on our strategic priorities and their effect on our results; limits on our ability to use net operating loss carryovers to reduce future tax payments; delays in
obtaining regulatory approvals; disruptions in the financial markets or decreases in the appraised values or performance of our communities that affect our ability to obtain financing or extend or refinance debt as it matures and our financing
costs; our ability to generate sufficient cash flow to cover required interest, principal, and long-term lease payments and to fund our planned capital projects; the effect of our <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any of
our debt or lease agreements (including the financial covenants contained therein), including the risk of lenders or lessors declaring a cross default in the event of our <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any such
agreements and the risk of loss of our property securing leases and indebtedness due to any resulting lease terminations and foreclosure actions; the effect of our indebtedness and long-term leases on our liquidity and our ability to operate our
business; increases in market interest rates that increase the costs of our debt obligations; our ability to obtain additional capital on terms acceptable to us; departures of key officers and potential disruption caused by changes in management;
increased competition for, or a shortage of, associates (including due to the pandemic or general labor market conditions), wage pressures resulting from increased competition, low unemployment levels, minimum wage increases and changes in overtime
laws, and union activity; environmental contamination at any of our communities; failure to comply with existing environmental laws; an adverse determination or resolution of complaints filed against us, including putative class action complaints;
the cost and difficulty of complying with increasing and evolving regulation; costs to respond to, and adverse determinations resulting from, government reviews, audits and investigations; changes in, or our failure to comply with,
employment-related laws and regulations; unanticipated costs to comply with legislative or regulatory developments; the risks associated with current global economic conditions and general economic factors such as inflation, the consumer price
index, commodity costs, fuel and other energy costs, competition in the labor market, costs of salaries, wages, benefits, and insurance, interest rates, and tax rates; the impact of seasonal contagious illness or an outbreak of <FONT
STYLE="white-space:nowrap">COVID-19</FONT> or other contagious disease in the markets in which we operate; actions of activist stockholders, including a proxy contest; as well as other risks detailed from time to time in our filings with the
Securities and Exchange Commission, including those set forth under &#147;<I>Risk Factors</I>&#148; included elsewhere in this prospectus and in the documents incorporated by reference in this prospectus. When considering forward-looking statements,
you should keep in mind the risk factors and other cautionary statements in such SEC filings, press releases and other communications. Readers are cautioned not to place undue reliance on any of these forward-looking statements, which reflect
management&#146;s views as of the date of this prospectus. We cannot guarantee future results, levels of activity, performance or achievements, and, except as required by law, we expressly disclaim any obligation to release publicly any updates or
revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or change in events, conditions or circumstances on which any statement is based. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_4"></A>THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are the nation&#146;s premier operator of senior living communities, operating and managing 672 communities in 41 states as of
September&nbsp;30, 2022, with the ability to serve more than 60,000 residents. We offer our residents access to a broad continuum of services across the most attractive sectors of the senior living industry. We operate and manage independent living,
assisted living, memory care, and continuing care retirement communities (&#147;<B>CCRCs</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our goal is to be the first choice
in senior living by being the nation&#146;s most trusted and effective senior living provider and employer. Our senior living communities and our comprehensive network help to provide seniors with care and services in an environment that feels like
home. Our expertise in healthcare, hospitality, and real estate provides residents with opportunities to improve wellness, pursue passions, and stay connected with friends and loved ones. By providing residents with a range of service options as
their needs change, we provide greater continuity of care, enabling seniors to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">age-in-place,</FONT></FONT> which we believe enables them to maintain residency with us for a longer
period of time. The ability of residents to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">age-in-place</FONT></FONT> is also beneficial to our residents&#146; families who are concerned with care decisions for their elderly
relatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive offices are located at 111 Westwood Place, Suite 400, Brentwood, Tennessee 37027 and our telephone
number at that address is (615) <FONT STYLE="white-space:nowrap">221-2250.</FONT> Our website address is www.brookdale.com. The information on, or accessible through, our website is not part of this prospectus or any prospectus supplement and should
not be relied upon in connection with making any investment decision with respect to the securities offered by this prospectus or any prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_5"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in our securities involves risk. See the risk factors described in our most recent Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> (together with any material changes thereto contained in subsequently filed Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q)</FONT> and those contained in our other filings with the SEC that are
incorporated by reference in this prospectus and any accompanying prospectus supplement. Before making an investment decision, you should carefully consider these risks as well as other information we include or incorporate by reference in this
prospectus and any accompanying prospectus supplement. These risks could materially affect our business, financial condition or results of operations and cause the value of our securities to decline. You could lose all or part of your investment.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise set forth in a prospectus supplement, we intend to use the net proceeds of any offering of securities for working capital and
other general corporate purposes, which may include the repayment or refinancing of outstanding indebtedness and the financing of future acquisitions. We will have significant discretion in the use of any net proceeds. The net proceeds may be
invested temporarily in interest-bearing accounts and short-term <FONT STYLE="white-space:nowrap">interest-bearing</FONT> securities until they are used for their stated purpose. We may provide additional information on the use of the net proceeds
from the sale of the offered securities in an applicable prospectus supplement relating to the offered securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless set forth in an
accompanying prospectus supplement, we will not receive any proceeds in the event that securities are sold by a selling securityholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_7"></A>DESCRIPTION OF SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus contains summary descriptions of the common stock, preferred stock, depositary shares, debt securities, warrants, subscription
rights, purchase contracts and purchase units that may be offered and sold from time to time. These summary descriptions are not meant to be complete descriptions of each security. However, at the time of an offering and sale, this prospectus
together with the accompanying prospectus supplement will contain the material terms of the securities being offered. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_8"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this
prospectus, our authorized capital stock consists of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">400,000,000 shares of common stock, par value $0.01 per share; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">50,000,000 shares of preferred stock, par value $0.01 per share. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of November 4, 2022, there were outstanding 186,805,515 shares of common stock (excluding restricted shares and restricted stock units) and
no outstanding shares of preferred stock. All of the shares of common stock outstanding on the date of this prospectus are validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> under the Delaware General Corporation
Law (the &#147;<B>DGCL</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Set forth below is a summary description of the material terms of our capital stock. This description
is qualified in its entirety by reference to our amended and restated certificate of incorporation and amended and restated bylaws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each holder of common stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of
stockholders. Except as provided with respect to any other class or series of stock, the holders of our common stock possess the exclusive right to vote for the election of directors and for all other purposes. The amended and restated certificate
of incorporation does not provide for cumulative voting in the election of directors. The holders of common stock have no preemptive, subscription, redemption or conversion rights. Any shares of common stock sold under this prospectus will be fully
paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> upon issuance against full payment of the purchase price for such shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to any preference rights of holders of our preferred stock that the Company may issue in the future, the holders of our common stock
are entitled to receive dividends, if any, declared from time to time by our board of directors out of legally available funds. In the event of our liquidation, dissolution or winding up, the holders of our common stock are entitled to share ratably
in all assets remaining after the payment of liabilities, subject to any rights of our holders of preferred stock to prior distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed and principally traded on the NYSE under the symbol &#147;BKD.&#148; On November&nbsp;15, 2022, the last reported
sale price of our common stock on the NYSE was $4.92 per share. As of November&nbsp;14, 2022, there were 356 holders of record of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The board of directors
has the authority, without action by our stockholders, to issue preferred stock and to fix voting powers for each class or series of preferred stock, and to provide that any class or series may be subject to redemption, entitled to receive
dividends, entitled to rights upon dissolution or convertible into, or exchangeable for, shares of any other class or classes of capital stock. The rights with respect to a series or class of preferred stock may be greater than the rights attached
to our common stock. It is not possible to state the actual effect of the issuance of any shares of our preferred stock on the rights of holders of our common stock until our board of directors determines the specific rights attached to that
preferred stock. The effect of issuing preferred stock could include one or more of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restricting dividends in respect of our common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">diluting the voting power of our common stock or providing that holders of preferred stock have the right to vote
on matters as a class; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impairing the liquidation rights of our common stock; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delaying or preventing a change of control of us. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of Delaware Law, Our Amended and Restated Certificate of Incorporation and Our Amended and Restated Bylaws</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws that
may be deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider to be in its best interest, including those attempts that might result in a premium over the market
price for the shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Authorized but Unissued Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The authorized but unissued shares of our common stock and our preferred stock will be available for future issuance without approval by our
stockholders. These additional shares may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. For our preferred stock, the board of
directors is authorized to determine and alter all rights, preferences, privileges, qualifications, limitations and restrictions without limitation. The existence of authorized but unissued shares of our common stock and our preferred stock could
render more difficult or discourage an attempt to obtain control over us by means of a proxy contest, tender offer, merger or otherwise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Delaware
Business Combination Statute </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are organized under Delaware law. Some provisions of Delaware law may delay or prevent a
transaction that would cause a change in our control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides that
Section&nbsp;203 of the DGCL, an anti-takeover law, will not apply to us. In general, this statute prohibits a publicly held Delaware corporation from engaging in a business combination with an interested stockholder for a period of three years
after the date of the transaction by which that person became an interested stockholder, unless the business combination is approved in a prescribed manner. For purposes of Section&nbsp;203, a business combination includes a merger, asset sale or
other transaction resulting in a financial benefit to the interested stockholder, and an interested stockholder is a person who, together with affiliates and associates, owns, or within three years prior, did own, 15% or more of voting stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Composition of the Board of Directors; Election and Removal of Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors may consist of not less than three nor more than nine directors. In an uncontested election, directors are elected by a
majority of the votes of the shares present in person or represented by proxy and entitled to vote on the election of directors. In a contested election, a plurality voting standard applies to director elections. Since the 2021 annual meeting of
stockholders, all directors have been and will be elected for a <FONT STYLE="white-space:nowrap">one-year</FONT> term expiring at the next annual meeting of stockholders. There is no cumulative voting in the election of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated Bylaws</I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws may make a change in control of the
Company more difficult to effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and amended and restated bylaws also provide that
our stockholders are specifically denied the ability to call a special meeting of the stockholders. Our amended and restated certificate of incorporation and amended and restated bylaws also do not provide for the right of stockholders to act by
written consent without a meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated bylaws require that advance notice must be provided by our
stockholders to nominate persons for election to our board of directors as well as to propose actions to be taken at an annual meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amendment of any of the provisions in our amended and restated certificate of incorporation requires approval by a stockholder vote by the
holders of at least a majority of the voting power of the then outstanding voting stock. The bylaws may be amended by the affirmative vote of at least a majority of the whole board of directors or by the affirmative vote of the holders of at least <FONT
STYLE="white-space:nowrap">sixty-six</FONT> and <FONT STYLE="white-space:nowrap">two-thirds</FONT> percent (66 2/3%) of the voting power of the then outstanding voting stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations on Liability and Indemnification of Directors and Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides that our directors will not be personally liable to us or our stockholders for
monetary damages for breach of a fiduciary duty as a director, except for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any breach of the director&#146;s duty of loyalty to us or our stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">liability under Delaware corporate law for an unlawful payment of dividends or an unlawful stock purchase or
redemption of stock; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any transaction from which the director derives an improper personal benefit. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation allows us to indemnify our directors and officers to the fullest extent permitted by
Delaware law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated bylaws allows us to indemnify our directors and officers to the fullest extent permitted by
Delaware law. Our amended and restated bylaws also obligate us to advance expenses incurred by a director or officer in advance of the final disposition of any action, suit or proceeding, and permit us to secure insurance on behalf of any officer or
director for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be permitted to indemnify him or her under our amended and restated certificate of incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into indemnification agreements with our directors and executive officers. We believe that these bylaw provisions and
indemnification agreements are necessary to attract and retain qualified persons as directors and officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The limitation of liability
and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against the directors and officers for breach of their fiduciary duty. They
may also reduce the likelihood of derivative litigation against the directors and officers, even though an action, if successful, might benefit the Company and its stockholders. Furthermore, a stockholder&#146;s investment may be adversely affected
to the extent that we pay the costs of settlement and damage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities
Act, may be permitted to directors, officers or persons controlling the registrant pursuant to the foregoing provisions, we have been informed that, in the opinion of the SEC such indemnification is against public policy as expressed in the
Securities Act and is therefore unenforceable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for our common stock is American Stock Transfer&nbsp;&amp; Trust Company, LLC. The telephone number of
American Stock Transfer&nbsp;&amp; Trust Company, LLC is (718) <FONT STYLE="white-space:nowrap">921-8124.</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_9"></A>DESCRIPTION OF DEPOSITARY SHARES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may offer depositary receipts representing fractional shares of our preferred stock, rather than full shares of preferred stock. The shares
of preferred stock represented by depositary shares will be deposited under a depositary agreement between us and a bank or trust company that meets certain requirements and is selected by us (the &#147;<B>Bank Depositary</B>&#148;). Each owner of a
depositary share will be entitled to all the rights and preferences of the preferred stock represented by the depositary share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
description in an accompanying prospectus supplement of any depositary shares we offer will not necessarily be complete and will be qualified in its entirety by reference to the applicable depositary agreement, which will be filed with the SEC if we
offer depositary shares. For more information on how you can obtain copies of any depositary agreement if we offer depositary shares, see &#147;<I>Where You Can Find More Information</I>.&#148; We urge you to read the applicable depositary agreement
and any accompanying prospectus supplement in their entirety. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends and Other Distributions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we pay a cash distribution or dividend on a series of preferred stock represented by depositary shares, the Bank Depositary will distribute
such dividends to the record holders of such depositary shares. If the distributions are in property other than cash, the Bank Depositary will distribute the property to the record holders of the depositary shares. However, if the Bank Depositary
determines that it is not feasible to make the distribution of property, the Bank Depositary may, with our approval, sell such property and distribute the net proceeds from such sale to the record holders of the depositary shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption of Depositary Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we
redeem a series of preferred stock represented by depositary shares, the Bank Depositary will redeem the depositary shares from the proceeds received by the Bank Depositary in connection with the redemption. The redemption price per depositary share
will equal the applicable fraction of the redemption price per share of the preferred stock. If fewer than all the depositary shares are redeemed, the depositary shares to be redeemed will be selected by lot or pro rata as the Bank Depositary may
determine. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting the Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon receipt of notice of any meeting at which the holders of the preferred stock represented by depositary shares are entitled to vote, the
Bank Depositary will mail the notice to the record holders of the depositary shares relating to such preferred stock. Each record holder of these depositary shares on the record date, which will be the same date as the record date for the preferred
stock, may instruct the Bank Depositary as to how to vote the preferred stock represented by such holder&#146;s depositary shares. The Bank Depositary will endeavor, insofar as practicable, to vote the amount of the preferred stock represented by
such depositary shares in accordance with such instructions, and we will take all action that the Bank Depositary deems necessary in order to enable the Bank Depositary to do so. The Bank Depositary will abstain from voting shares of the preferred
stock to the extent it does not receive specific instructions from the holders of depositary shares representing such preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amendment and
Termination of the Depositary Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The form of depositary receipt evidencing the depositary shares and any provision of the
depositary agreement may be amended by agreement between the Bank Depositary and us. However, any amendment that materially and adversely alters the rights of the holders of depositary shares will not be effective unless such amendment has been
approved by the holders of at least a majority of the depositary shares then outstanding. The depositary agreement may be terminated by the Bank Depositary or us only if (1)&nbsp;all outstanding depositary
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shares have been redeemed or (2)&nbsp;there has been a final distribution in respect of the preferred stock in connection with any liquidation, dissolution or winding up of our company and such
distribution has been distributed to the holders of depositary receipts. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Withdrawal of Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as may be provided otherwise in an accompanying prospectus supplement, upon surrender of depositary receipts at the principal office of
the Bank Depositary, subject to the terms of the depositary agreement, the owner of the depositary shares may demand delivery of the number of whole shares of preferred stock and all money and other property, if any, represented by those depositary
shares. Partial shares of preferred stock will not be issued. If the depositary receipts delivered by the holder evidence a number of depositary shares in excess of the number of depositary shares representing the number of whole shares of preferred
stock to be withdrawn, the Bank Depositary will deliver to such holder at the same time a new depositary receipt evidencing the excess number of depositary shares. Holders of withdrawn preferred stock may not thereafter deposit those shares under
the depositary agreement or receive depositary receipts evidencing depositary shares therefor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_10"></A>DESCRIPTION OF DEBT SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may offer secured or unsecured debt securities which may be senior, subordinated or junior subordinated, and which may be convertible. We
may issue debt securities in one or more series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following description briefly sets forth certain general terms and provisions of the
debt securities. The particular terms of the debt securities offered by any prospectus supplement and the extent, if any, to which these general provisions may apply to the debt securities, will be described in the applicable prospectus supplement.
The form of indenture is filed as an exhibit to the registration statement of which this prospectus forms a part. The terms of the debt securities will include those set forth in the indenture, any related securities documents and those made a part
of the indenture by the Trust Indenture Act of 1939, as amended (the &#147;<B>Trust Indenture Act</B>&#148;). You should read the summary below, the applicable prospectus supplement and the provisions of the indenture and any related security
documents, if any, in their entirety before investing in our debt securities. Capitalized terms used in the summary have the meanings specified in the indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement relating to any series of debt securities that we may offer will contain the specific terms of the debt securities.
These terms may include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title and aggregate principal amount of the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the debt securities will be senior, subordinated or junior subordinated; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the debt securities will be secured or unsecured; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">applicable subordination provisions, if any; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the debt securities are convertible or exchangeable into other securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the percentage or percentages of principal amount at which such debt securities will be issued;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the interest rate(s) or the method for determining the interest rate(s); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the dates on which interest will accrue or the method for determining dates on which interest will accrue and
dates on which interest will be payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the maturity date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">redemption or early repayment provisions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">authorized denominations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">form; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">amount of discount or premium, if any, with which such debt securities will be issued; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether such debt securities will be issued in whole or in part in the form of one or more global securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the identity of the depositary for global securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether a temporary security is to be issued with respect to such series and whether any interest payable prior
to the issuance of definitive securities of the series will be credited to the account of the persons entitled thereto; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms upon which beneficial interests in a temporary global security may be exchanged in whole or in part for
beneficial interests in a definitive global security or for individual definitive securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any covenants applicable to the particular debt securities being issued; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any defaults and events of default applicable to the particular debt securities being issued;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the guarantors of each series, if any, and the extent of the guarantees (including provisions relating to
seniority, subordination, security and release of the guarantees), if any; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any applicable subordination provisions for any subordinated debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any restriction or condition on the transferability of the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency, currencies or currency units in which the purchase price for, the principal of and any premium and
any interest on, such debt securities will be payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the time period within which, the manner in which and the terms and conditions upon which the purchaser of the
debt securities can select the payment currency; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the securities exchange(s) on which the securities will be listed, if any; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether any underwriter(s) will act as market maker(s) for the securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which a secondary market for the securities is expected to develop; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our obligation or right to redeem, purchase or repay debt securities under a sinking fund, amortization or
analogous provision; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provisions relating to covenant defeasance and legal defeasance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provisions relating to satisfaction and discharge of the indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provisions relating to the modification of the indenture both with and without the consent of holders of debt
securities issued under the indenture; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additional terms not inconsistent with the provisions of the indenture. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may sell the debt securities,
including original issue discount securities, at par or at a substantial discount below their stated principal amount. Unless we inform you otherwise in a prospectus supplement, we may issue additional debt securities of a particular series without
the consent of the holders of the debt securities of such series outstanding at the time of issuance. Any such additional debt securities, together with all other outstanding debt securities of that series, will constitute a single series of
securities under the indenture. In addition, we will describe in the applicable prospectus supplement, material U.S. federal income tax considerations and any other special considerations for any debt securities we sell which are denominated in a
currency or currency unit other than U.S. dollars. Unless we inform you otherwise in the applicable prospectus supplement, the debt securities will not be listed on any securities exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">United States federal income tax consequences and special considerations, if any, applicable to any such series will be described in an
accompanying prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect most debt securities to be issued in fully registered form without coupons and in
denominations of $2,000 and any integral multiples thereof. Subject to the limitations provided in the indenture and in the applicable prospectus supplement, debt securities that are issued in registered form may be transferred or exchanged at the
corporate office of the trustee or the principal corporate trust office of the trustee, without the payment of any service charge, other than any tax or other governmental charge payable in connection therewith. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Global Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless we inform you
otherwise in the applicable prospectus supplement, the debt securities of a series may be issued in whole or in part in the form of one or more global securities that will be deposited with, or on behalf of, a depositary identified in the applicable
prospectus supplement. Global securities will be issued in registered form and in either temporary or definitive form. Unless and until it is exchanged in whole or in part for the individual debt securities, a global security may not be transferred
except as a whole by the depositary for such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
global security to a nominee of such depositary or by a nominee of such depositary to such depositary or another nominee of such depositary or by such depositary or any such nominee to a
successor of such depositary or a nominee of such successor. The specific terms of the depositary arrangement with respect to any debt securities of a series and the rights of and limitations upon owners of beneficial interests in a global security
will be described in the applicable prospectus supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture and the debt securities shall be construed in accordance with and governed by the laws of the State of New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_11"></A>DESCRIPTION OF WARRANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue warrants for the purchase of shares of our common stock, shares of preferred stock or our debt securities. We may issue warrants
independently or together with other securities, and they may be attached to or separate from the other securities. Each series of warrants will be issued under a separate warrant agreement that we will enter into with a bank or trust company, as
warrant agent, as detailed in an accompanying prospectus supplement. The warrant agent will act solely as our agent in connection with the warrants and will not assume any obligation, or agency or trust relationship, with you. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement relating to a particular issue of warrants will describe the terms of those warrants, including, when applicable:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the offering price; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency or currencies, including composite currencies, in which the purchase price and/or exercise price of
the warrants may be payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of warrants offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the exercise price and the amount of securities you will receive upon exercise; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the procedure for exercise of the warrants and the circumstances, if any, that will cause the warrants to be
automatically exercised; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rights, if any, we have to redeem the warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which the right to exercise the warrants will commence and the date on which the warrants will
expire; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name of the warrant agent; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other material terms of the warrants. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After warrants expire they will become void. The prospectus supplement may provide for the adjustment of the exercise price of the warrants.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Warrants may be exercised at the appropriate office of the warrant agent or any other office indicated in an accompanying prospectus
supplement. Before the exercise of warrants, holders will not have any of the rights of holders of the securities purchasable upon exercise and will not be entitled to payments made to holders of those securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The description in an accompanying prospectus supplement of any warrants we offer will not necessarily be complete and will be qualified in
its entirety by reference to the applicable warrant agreement, which will be filed with the SEC if we offer warrants. For more information on how you can obtain copies of any warrant agreement if we offer warrants, see &#147;<I>Where You Can Find
More Information</I>.&#148; We urge you to read the applicable warrant agreement and any accompanying prospectus supplement in their entirety. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_12"></A>DESCRIPTION OF SUBSCRIPTION RIGHTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue subscription rights to purchase shares of our common stock, shares of our preferred stock or our debt securities. We may issue
subscription rights independently or together with any other offered security, which may or may not be transferable by the stockholder. In connection with any offering of subscription rights, we may enter into a standby arrangement with one or more
underwriters or other purchasers pursuant to which the underwriters or other purchasers may be required to purchase any securities remaining unsubscribed for after such offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement relating to any subscription rights we may offer will contain the specific terms of the subscription rights. These
terms may include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price, if any, for the subscription rights; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number and terms of each share of common stock or preferred stock or debt securities which may be purchased
per each subscription right; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the exercise price payable for each share of common stock or preferred stock or debt securities upon the exercise
of the subscription rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which the subscription rights are transferable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any provisions for adjustment of the number or amount of securities receivable upon exercise of the subscription
rights or the exercise price of the subscription rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms of the subscription rights, including the terms, procedures and limitations relating to the
exchange and exercise of the subscription rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which the right to exercise the subscription rights shall commence, and the date on which the
subscription rights shall expire; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which the subscription rights may include an over-subscription privilege with respect to
unsubscribed securities; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, the material terms of any standby underwriting or purchase arrangement entered into by us in
connection with the offering of subscription rights. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The description in an accompanying prospectus supplement of any
subscription rights we offer will not necessarily be complete and will be qualified in its entirety by reference to the applicable subscription rights certificate or subscription rights agreement, which will be filed with the SEC if we offer
subscription rights. For more information on how you can obtain copies of any subscription rights certificate or subscription rights agreement if we offer subscription rights, see &#147;<I>Where You Can Find More Information</I>.&#148; We urge you
to read the applicable subscription rights certificate, the applicable subscription rights agreement and any accompanying prospectus supplement in their entirety. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_13"></A>DESCRIPTION OF PURCHASE CONTRACTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue, from time to time, purchase contracts, including contracts entitling and/or obligating holders to purchase from us and requiring
us to sell to the holders, a specified principal amount of debt securities, shares of common stock or preferred stock, depositary shares, government securities, or other securities that we may sell under this prospectus at a future date or dates.
The consideration payable upon settlement of the purchase contracts may be fixed at the time the purchase contracts are issued or may be determined by a specific reference to a formula set forth in the purchase contracts. The purchase contracts may
be issued separately or as part of units consisting of a purchase contract and other securities or obligations issued by us or third parties, including United States treasury securities, securing the holders&#146; obligations to purchase the
relevant securities under the purchase contracts. The purchase contracts may require us to make periodic payments to the holders of the purchase contracts or units or vice versa, and the payments may be unsecured or prefunded on some basis. The
purchase contracts may require holders to secure their obligations under the purchase contracts and, in certain circumstances, we may deliver a newly issued prepaid purchase contract, which is referred to as a &#147;prepaid security,&#148; upon
release to a holder of any collateral securing such holder&#146;s obligations under the original contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement
related to any particular purchase contracts and, if applicable, prepaid security, will describe, among other things, the material terms of the purchase contracts and of the securities being sold pursuant to such purchase contracts, and, if
applicable, the prepaid securities and the documents pursuant to which such prepaid securities will be issued, a discussion, if appropriate, of any special United States federal income tax considerations applicable to the purchase contracts and any
material provisions governing the purchase contracts that differ from those described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The description in an accompanying
prospectus supplement of any purchase contract we offer will not necessarily be complete and will be qualified in its entirety by reference to the purchase contracts and, if applicable, collateral arrangements and depositary arrangements, relating
to the purchase contracts. Alternatively, purchase contracts may require holders to satisfy their obligations thereunder when the purchase contracts are issued. For more information on how you can obtain copies of any purchase contract we may offer,
see &#147;<I>Where You Can Find More Information</I>.&#148; We urge you to read the applicable purchase contract and any accompanying prospectus supplement in their entirety. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_14"></A>DESCRIPTION OF PURCHASE UNITS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may, from time to time, issue units comprised of one or more of certain other securities that may be offered under this prospectus, in any
combination. Each unit may also include debt obligations of third parties, such as U.S. Treasury securities. Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit
will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately at any time, or at any time
before a specified date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any prospectus supplement related to any particular units will describe, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the material terms of the units and of the securities comprising the units, including whether and under what
circumstances those securities may be held or transferred separately; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, the prepaid securities and the documents pursuant to which such prepaid securities will be issued;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any material provisions relating to the issuance, payment, settlement, transfer or exchange of the units or of
the securities comprising the units; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if appropriate, any special United States federal income tax considerations applicable to the units; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any material provisions of the governing unit agreement that differ from those described above.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The description in an accompanying prospectus supplement of any purchase unit we offer will not necessarily be complete
and will be qualified in its entirety by reference to the purchase units and, if applicable, collateral arrangements and depositary arrangements, relating to the purchase units. Alternatively, purchase units may require holders to satisfy their
obligations thereunder when the purchase units are issued. For more information on how you can obtain copies of any purchase unit we may offer, see &#147;<I>Where You Can Find More Information</I>.&#148; We urge you to read the applicable purchase
unit and any accompanying prospectus supplement in their entirety. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_15"></A>SELLING SECURITYHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information about selling securityholders, where applicable, will be set forth in a prospectus supplement, in a post-effective amendment or in
filings we make with the SEC under the Exchange Act which are incorporated by reference into this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_16"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or the selling securityholders may sell the applicable securities offered by this prospectus from time to time in one or more transactions,
including without limitation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directly to one or more purchasers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through agents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to or through underwriters, brokers or dealers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through a combination of any of these methods. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A distribution of the securities offered by this prospectus may also be effected through the issuance of derivative securities, including
without limitation, warrants, subscriptions, exchangeable securities, forward delivery contracts and the writing of options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition,
the manner in which we or the selling securityholders may sell some or all of the securities covered by this prospectus, include, without limitation, through: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a block trade in which a broker-dealer will attempt to sell as agent, but may position or resell a portion of the
block, as principal, in order to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker-dealer, as principal, and resale by the broker-dealer for its account;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which a broker solicits purchasers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">settlement of short sales; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transactions through broker-dealers to sell a specified number of such securities at a stipulated price per
security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exchange distribution in accordance with the rules of the applicable exchange; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods of sale. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or the selling securityholders may also enter into hedging transactions. For example, we or the selling securityholders may: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into transactions with a broker-dealer or affiliate thereof in connection with which such broker-dealer or
affiliate will engage in short sales of the common stock pursuant to this prospectus, in which case such broker-dealer or affiliate may use shares of common stock received from us or the selling securityholders to close out its short positions;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sell securities short and redeliver such shares to close out our short positions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into option or other types of transactions that require us or the selling securityholders to deliver common
stock to a broker-dealer or an affiliate thereof, who will then resell or transfer the common stock under this prospectus; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">loan or pledge the common stock to a broker-dealer or an affiliate thereof, who may sell the loaned shares or, in
an event of default in the case of a pledge, sell the pledged shares pursuant to this prospectus. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we or
the selling securityholders may enter into derivative or hedging transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. In connection with such a transaction, the
third parties may sell the applicable securities covered by and pursuant to this prospectus and an applicable prospectus supplement or pricing supplement, as the case may be. If so, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
third party may use securities borrowed from us, the selling securityholders or others to settle such sales and may use securities received from us or the selling securityholders to close out any
related short positions. We or the selling securityholders may also loan or pledge securities covered by this prospectus and an applicable prospectus supplement to third parties, who may sell the loaned securities or, in an event of default in the
case of a pledge, sell the pledged securities pursuant to this prospectus and the applicable prospectus supplement or pricing supplement, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A prospectus supplement with respect to each offering of securities will state the terms of the offering of the securities, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name or names of any underwriters or agents and the amounts of securities underwritten or purchased by each
of them if any; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the public offering price or purchase price of the securities and the net proceeds to be received by us or the
selling securityholders from the sale; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any delayed delivery arrangements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any underwriting discounts or agency fees and other items constituting underwriters&#146; or agents&#146;
compensation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any discounts or concessions allowed or reallowed or paid to dealers; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any securities exchange or markets on which the securities may be listed. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offer and sale of the securities described in this prospectus by us, the selling securityholders, the underwriters or the third parties
described above may be effected from time to time in one or more transactions, including privately negotiated transactions, either: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a fixed price or prices, which may be changed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at market prices prevailing at the time of sale; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at prices related to the prevailing market prices; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at negotiated prices. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any public offering price and
any discounts, commissions, concessions or other items constituting compensation allowed or reallowed or paid to underwriters, dealers, agents or remarketing firms may be changed from time to time. Any underwriters, dealers, agents and remarketing
firms that participate in the distribution of the offered securities may be &#147;underwriters&#148; as defined in the Securities Act. Any discounts or commissions they receive from us or the selling securityholders and any profits they receive on
the resale of the offered securities may be treated as underwriting discounts and commissions under the Securities Act. We will identify any underwriters, agents or dealers and describe their commissions, fees or discounts in the applicable
prospectus supplement or pricing supplement, as the case may be. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Underwriters and Agents </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If underwriters are used in a sale, they will acquire the offered securities for their own account. The underwriters may resell the offered
securities in one or more transactions, including negotiated transactions. These sales may be made at a fixed public offering price or prices, which may be changed, at market prices prevailing at the time of the sale, at prices related to such
prevailing market price or at negotiated prices. We or the selling securityholders may offer the securities to the public through an underwriting syndicate or through a single underwriter. The underwriters in any particular offering will be
mentioned in the applicable prospectus supplement or pricing supplement, as the case may be. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in connection with any particular offering of securities, the
obligations of the underwriters to purchase the offered securities will be subject to certain conditions contained in an underwriting agreement that we or the selling securityholders will enter into with the underwriters at the time of the sale to
them. The underwriters will be obligated to purchase all of the securities of the series offered if any of the securities are purchased, unless otherwise specified in connection with any particular offering of securities. Any initial offering price
and any discounts or concessions allowed, reallowed or paid to dealers may be changed from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or the selling
securityholders may designate agents to sell the offered securities. Unless otherwise specified in connection with any particular offering of securities, the agents will agree to use their best efforts to solicit purchases for the period of their
appointment. We or the selling securityholders may also sell the offered securities to one or more remarketing firms, acting as principals for their own accounts or as agents for us or the selling securityholders. These firms will remarket the
offered securities upon purchasing them in accordance with a redemption or repayment pursuant to the terms of the offered securities. A prospectus supplement or pricing supplement, as the case may be will identify any remarketing firm and will
describe the terms of its agreement, if any, with us and its compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with offerings made through underwriters or
agents, we or the selling securityholders may enter into agreements with such underwriters or agents pursuant to which we or the selling securityholders receive our outstanding securities in consideration for the securities being offered to the
public for cash. In connection with these arrangements, the underwriters or agents may also sell securities covered by this prospectus to hedge their positions in these outstanding securities, including in short sale transactions. If so, the
underwriters or agents may use the securities received from us or the selling securityholders under these arrangements to close out any related open borrowings of securities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dealers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or the selling
securityholders may sell the offered securities to dealers as principals. We or the selling securityholders may negotiate and pay dealers&#146; commissions, discounts or concessions for their services. The dealer may then resell such securities to
the public either at varying prices to be determined by the dealer or at a fixed offering price agreed to with us or the selling securityholders at the time of resale. Dealers engaged by us or the selling securityholders may allow other dealers to
participate in resales. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Direct Sales </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or the selling securityholders may choose to sell the offered securities directly. In this case, no underwriters or agents would be
involved. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">At-the-Market</FONT></FONT> Offerings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or the selling securityholders may also sell the securities offered by any applicable prospectus supplement in <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;at-the-market</FONT></FONT> offerings&#148; within the meaning of Rule 415 of the Securities Act, to or through a market maker or into an existing trading market, on an exchange or
otherwise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Institutional Purchasers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or the selling securityholders may authorize agents, dealers or underwriters to solicit certain institutional investors to purchase offered
securities on a delayed delivery basis pursuant to delayed delivery contracts providing for payment and delivery on a specified future date. The applicable prospectus supplement or pricing supplement, as the case may be, will provide the details of
any such arrangement, including the offering price and commissions payable on the solicitations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or the selling securityholders will enter into such delayed contracts only with
institutional purchasers that we approve. These institutions may include commercial and savings banks, insurance companies, pension funds, investment companies and educational and charitable institutions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification; Other Relationships </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
or the selling securityholders may have agreements with agents, underwriters, dealers and remarketing firms to indemnify them against certain civil liabilities, including liabilities under the Securities Act. Agents, underwriters, dealers and
remarketing firms, and their affiliates, may engage in transactions with, or perform services for, us or the selling securityholders in the ordinary course of business. This includes commercial banking and investment banking transactions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market-Making, Stabilization and Other Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is currently no market for any of the offered securities, other than the common stock which is listed on the NYSE. If the offered
securities are traded after their initial issuance, they may trade at a discount from their initial offering price, depending upon prevailing interest rates, the market for similar securities and other factors. While it is possible that an
underwriter could inform us that it intends to make a market in the offered securities, such underwriter would not be obligated to do so, and any such market-making could be discontinued at any time without notice. Therefore, no assurance can be
given as to whether an active trading market will develop for the offered securities. We have no current plans for listing of the preferred stock or debt securities on any securities exchange or quotation system; any such listing with respect to any
preferred stock or any debt securities will be described in the applicable prospectus supplement or pricing supplement, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with any offering of common stock, preferred stock, debt securities or securities that provide for the issuance of shares of our
common stock upon conversion, exchange or exercise, as the case may be, the underwriters may purchase and sell shares of common stock, preferred stock or our debt securities in the open market. These transactions may include short sales, syndicate
covering transactions and stabilizing transactions. Short sales involve syndicate sales of common stock in excess of the number of shares to be purchased by the underwriters in the offering, which creates a syndicate short position.
&#147;<B>Covered</B>&#148; short sales are sales of shares made in an amount up to the number of shares represented by the underwriters&#146; over-allotment option. In determining the source of shares to close out the covered syndicate short
position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the over-allotment option. Transactions to close out the
covered syndicate short involve either purchases of the common stock in the open market after the distribution has been completed or the exercise of the over-allotment option. The underwriters may also make &#147;naked&#148; short sales of shares in
excess of the over-allotment option. The underwriters must close out any naked short position by purchasing shares of common stock in the open market. A naked short position is more likely to be created if the underwriters are concerned that there
may be downward pressure on the price of the shares in the open market after pricing that could adversely affect investors who purchase in the offering. Stabilizing transactions consist of bids for or purchases of shares in the open market while the
offering is in progress for the purpose of pegging, fixing or maintaining the price of the securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with any offering,
the underwriters may also engage in penalty bids. Penalty bids permit the underwriters to reclaim a selling concession from a syndicate member when the securities originally sold by the syndicate member are purchased in a syndicate covering
transaction to cover syndicate short positions. Stabilizing transactions, syndicate covering transactions and penalty bids may cause the price of the securities to be higher than it would be in the absence of the transactions. The underwriters may,
if they commence these transactions, discontinue them at any time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_17"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in any accompanying prospectus supplement, Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP, New York, New York,
will provide opinions regarding the authorization and validity of the securities. Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP may also provide opinions regarding certain other matters. Any underwriters will be advised about legal matters by
their own counsel, which will be named in an accompanying prospectus supplement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc869187_18"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Brookdale Senior Living Inc. appearing in Brookdale Senior Living Inc.&#146;s Annual Report (Form <FONT
STYLE="white-space:nowrap">10-K)</FONT> for the year ended December&nbsp;31, 2021 (including the schedule appearing therein) and the effectiveness of Brookdale Senior Living Inc.&#146;s internal control over financial reporting as of
December&nbsp;31, 2021 have been audited by Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated financial
statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g869187g01a01.jpg" ALT="LOGO" STYLE="width:4.16667in;height:0.925692in;">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Brookdale Senior Living Inc. </B></P>
<P STYLE="margin-top:72pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Up to 54,968,244 Shares of common stock </B></P> <P STYLE="font-size:140pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus
Supplement </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:140pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>October&nbsp;23, 2024 </B></P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>d869187dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:bkd="http://www.brrokdale.com/20241023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:srt="http://fasb.org/srt/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31">
<head>
<title>EX-FILING FEES</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;"><div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P10_23_2024To10_23_2024" id="ixv-325">0001332349</ix:nonNumeric><ix:nonNumeric name="ffd:SubmissnTp" contextRef="P10_23_2024To10_23_2024" id="ixv-326">424B7</ix:nonNumeric><ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="P10_23_2024To10_23_2024" id="ixv-327">EX-FILING FEES</ix:nonNumeric><ix:nonNumeric name="ffd:PrevslyPdFlg" id="hidden123221170" contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis">false</ix:nonNumeric><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="P10_23_2024To10_23_2024" unitRef="Unit_USD" decimals="0" id="ixv-329">0</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"/></ix:references><ix:resources><xbrli:context id="P10_23_2024To10_23_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001332349</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-10-23</xbrli:startDate> <xbrli:endDate>2024-10-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001332349</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>1</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-10-23</xbrli:startDate> <xbrli:endDate>2024-10-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit></ix:resources></ix:header></div><div> <div> <div style="line-height:normal;background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right;"><div style="font-weight:bold;display:inline;">Exhibit 107 </div></div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Calculation of Filing Fee Table </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonNumeric name="ffd:FormTp" contextRef="P10_23_2024To10_23_2024" id="ixv-354">S-3</ix:nonNumeric></div> </div></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Form Type) </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P10_23_2024To10_23_2024" id="ixv-355">Brookdale Senior Living Inc.</ix:nonNumeric> </div></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Exact Name of Registrant as Specified in its Charter) </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;display:inline;">Table 1: Newly Registered and Carry Forward Securities </div></div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:99%;border:0;margin:0 auto">
<tr>
<td style="width:13%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:5%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:6%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:8%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:6%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:14%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:10%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:8%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:5%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:6%"/> </tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Security</div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Type</div> </td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Security</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Class</div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Title</div> </td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Fee</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Calculation</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">or&#160;Carry</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Forward</div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Rule</div> </td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Amount</div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Registered</div> </td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Proposed</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Maximum</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Offering</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Price Per</div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Unit</div> </td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Maximum</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Aggregate</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Offering</div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Price</div> </td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Fee</div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Rate</div> </td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Amount of</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Registration</div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Fee</div> </td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Carry</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Forward</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Form</div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Type</div> </td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Carry</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Forward</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">File</div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Number</div> </td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Carry</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Forward</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Initial</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">effective</div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">date</div> </td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Filing&#160;Fee</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Previously</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Paid In</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Connection</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">with</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Unsold</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Securities<br/>to&#160;be</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Carried</div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 7pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Forward</div> </td> </tr>
<tr style="font-size:1pt">
<td colspan="25" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="25" style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt; padding-right:2pt;vertical-align:bottom;text-align:center;">Newly Registered Securities</td> </tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="-sec-ix-hidden:hidden123221170;display:inline;">Fees&#160;to&#160;Be</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Paid</div> </td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis" id="ixv-356">Equity</ix:nonNumeric></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis" id="ixv-357">Common Stock, $0.01 par value per share</ix:nonNumeric>, issuable upon conversion of the Company&#8217;s 3.50% Convertible Senior Notes due 2029</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">Rule <ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis" format="ixt:fixed-true" id="ixv-358">457(c)</ix:nonNumeric></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><ix:nonFraction name="ffd:AmtSctiesRegd" contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-359">54,968,244</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">$<ix:nonFraction name="ffd:MaxOfferingPricPerScty" contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-360">6.26</ix:nonFraction><div style="font-size:75%; vertical-align:top;display:inline;font-size:8.3px">(1)</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">$<ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="P10_23_2024To10_23_2024" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-361"><ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-362">344,101,207.44</ix:nonFraction></ix:nonFraction><div style="font-size:75%; vertical-align:top;display:inline;font-size:8.3px">(1)</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">$<ix:nonFraction name="ffd:FeeRate" contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-363">0.00015310</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">$<ix:nonFraction name="ffd:FeeAmt" contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-364">52,681.89</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="7" style="padding-bottom:1pt ;vertical-align:bottom;text-align:right;">Total Offering Amounts&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">$<ix:nonFraction name="ffd:TtlFeeAmt" contextRef="P10_23_2024To10_23_2024" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-365">52,681.89</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="7" style="padding-bottom:1pt ;vertical-align:bottom;text-align:right;">Total&#160;Fees&#160;Previously&#160;Paid&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">N/A</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="7" style="padding-bottom:1pt ;vertical-align:bottom;text-align:right;">Total Fee Offsets&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;">N/A</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="7" style="padding-bottom:1pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:right;">Net Fee Due&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;">$<ix:nonFraction name="ffd:NetFeeAmt" contextRef="P10_23_2024To10_23_2024" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-366">52,681.89</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <ix:nonNumeric name="ffd:OfferingNote" contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis" escape="true" id="ixv-316">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low prices of the Registrant&#8217;s common stock as reported on the New York Stock Exchange on October <div style="display:inline;">22</div>, 2024. </div> </td> </tr> </table> </ix:nonNumeric></div> </div> </div> </div> </div>
</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g869187g01a01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g869187g01a01.jpg
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M*"@H*"@H*/_  !$( 18$X@,!(@ "$0$#$0'_Q  <  $  P$! 0$!
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MF:(I/P6'/?J)ZCJBQH;3,VW_ $?4 $B^
M
M
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M+Z),;1T,<K2  D7P
M
M
M                           'BO=RAM%HK+C5+E#31.E=TY)N3I7<8TO-
MRJ+O=:NX5CM:HJ9%D>O2J[DZ$W=AH/A$W=:+"%/;XW9/KYT1R<[&>$O^;4,W
MD5YY[/G>U\W%DC''2  _J)G&2-8G*N1PR'3MT6I#KK\)_J.G;Y.)K87\B.1%
MZEV'F1$1$1-R'ZFPZ=1.T[IP#^8G:T;'<Z(I_1RUP  3/170K47]]4J>!31J
MN?Z3MB>C6+:(OHZM2VW#[))6Y3U2\:[/>C?R4\FWM)035C:&SIJ<&.  '2<
M
M
M
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M
M
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MQIOYW+SJO*I[#^&S1.F="V1JRM3-S$7:B=/,?V2+\1$1M   ]
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MK;75SW-1R\=/JIFJ<S$0L9]/IL$1-XGFKX<^HS3/#MR>9.$!A?/;07GS4?\
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M1]WQM]%3V^F;!21)'&FW?FKEY555VJJ\JKM4] !TM1&W*  !Z
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M]/LWZ")Z+,2+BK!-NN,KD6J1O$U'TC=BKV['=I+#YZ]9I::SZ-VMHO6+1Z@
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M]10W!AQ.Z6GK\-U+\^)3NJES7<U5R>WRJB]JE\F#GQ3AR31N8,L9:1< !"E
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M]46(;+2W2V2\92U#=9J\K5W*U4Y%1=BF-J=+;!/SAKZ?4USQ\I=( %59
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M"LT==7/^R=T9M9)(W*.)>=K>?I7LR+-(M9K8RQW>/HDTFCG'/'?J  S6B
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MK8Y?!:L=2Q.E<VN]3"_#,G!<>J8VN;$^"MN<J]:2Q^]339G:^NV>6AH9WPP
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M5$<B=:*B_JE%ED\'=KW:4*%69ZK89E?U:BIZ\C4U=8MAMO\ )FZ6TURUV:U
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MNR@C=]RI6YN3G>NWT)EZ3JT[0T\^3NZ3/JAU542U51)/4/5\LCE<YR\JJ?(
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MJFPK#>*"_6N&X6FI94TDJ9M>U=R\J*G(J<RE36Z><5YM'25K1YXRTX9ZP]X
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M\;;[?1)30XJ<]M_J\UMH*2V445);Z:*FI8DR9%$U&M3L0](!2F=^JY$;
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M !*^C
M
M
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MK43)$1,D1#])HC:-GUVGP5P8XI4 !ZF
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M[:7W"JBEEB:YK-6/+/:O2IR\'8VHL4U51!1TU1"Z%B/59=7)45<N15 E0
M'%Q;B&GPU;&UM7#++&Z5(M6++/-45>54Y@.T",X-QC1XJ=5MHZ>HA[F1JNXW
M+;K9Y99*OYI)EW;-H %=2Z5[7#5/@GM]?&]CU8]%1G@JBY+^46)&]LD;7L<C
MF.1%14W*@'Z >"_76"RVFIN%7K+# W-4;O<N>2(G2J@>\$)PUI$H<07>*WT=
M!6-D>BJKWZNJU$3-57)?_<R;  0G$FD:W6&\3VZIHZN26'5S='JZJYM1>5>D
MEMKK&7&VTM;$US8ZB)LK6NWHCDSV^4#T@_'+DU5YDS*[I]+-FEJ8XI*6MA8Y
MR-61R-5&[=ZY+GD!8H/R-[9&-?&Y',<F:.1<T5.<_0 (KC#&U%A>JIX*RFJ9
MG3,5Z+%JY(F>7*J'6PQ>H<06>*XTT<D44BN1&R99IDJIR=0'4 #E1K55RHB)
MM55Y  (1?M)EBMDKH8'25\S5R7B$341?G+L7LS. FF*'7VV:34YTJ$S\FJ!:
MP(58=)-ANLK899)*&9VQ$J$1&JOSD7+RY$U145$5%S1>4
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M\_I%3V4[5Y"\88F0Q,BA8V.-B(UK&IDC43<B(?T"2(B&]I]-CT]>&D  /4X
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MS_/\M--1&M1K4R1$R1#] .VL
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MREATT$5- R&GC9%"Q-5K&)DC4Z$/H
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M^=7U !VU
M
M
M                               ")Z4<2IA?"%75QO1M9*G$4R<O&.1=
MO8F:]A+"K%MRZ1,>+6U*:V&+(]8H6K\&JG1?"5.=J*B9\^2<ZGDJ^HO:*\-/
M%/*/^_9]-!>#W6.R.N]PC5+E<&HJ([X4<6]$ZUWKV<Q9X B-N3O#BKAI%*^@
M #U*
M
M
M                          #FWV.:JI.X:>9:=U5G&Z9OPF,R\)6_I9;$
M7DSSY,E]-MH::VT$%%0PMAIH&HR-C=R(@ <1$<4R]( #L
M
M
M
$  ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g869187g01p02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g869187g01p02.jpg
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M 0$! 0$! ?_  !$( $0!+P,!$0 "$0$#$0'_Q  ?  $  @,  @,!
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M9!T*LX)4-E6N^X?;;:6J:9N&G>/V5DJOL&F5R_5 '/9[3H=AF*S;(4.P0!2
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M1$J1D?(\3'23D5.RCF6HV,-K\ZX>\&-'%N#UJ6%XK;1JO8ER8U'W5^2OGC[
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M:AU^$VM7=5F=G^P)%9CK5+US4K1:DX<V1F1(C$'W"?E0XDLY^.!**89$%9#
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MI)#8UAVOL^<6@V^[0N,AEMYR-C)&;<RT(CX251\4Q#5*OBIBH1&(SAEF2E$
M?GE;D\<\%W/\4C'R0.?ZGZ*/ Y'2EO8_T[P-:I+(^3S%II;=J5V"V<ME;!$F
M0RER3AC''+.>$'#>U"L%.NOM0 1U,77NUVEW790HEC8DM3QIR6#C(NN:Y<?J
M8C#LB6T(.*F0CGL6(_#CCR$*Q)S1OOSG*4I0A7LY$O<LS,![A0,0 L?*CR>
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M@-([L57DBM9KOPYI2^5&\5'7\#:)>J3P5AAXBZF'*CB3(MW)4:;*@01 )+;
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MBO-7C1@_M(:U:9YE+DNG=X37D421$EY%,B>G%=\A^OJS!T3N%/\ 6[<2(<=
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MDSI)<@B')%%AH:/MF:RFWI]OX?#89\O$V-DM6K8N4J<<.3OW3 LER22#)3/
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MNV7B*DB8*5ZD#IVY^8@4#:.WMU[3Q;XN,;>NHUN6V)7O9&!E,L<*&,JN,D#
M&+L&Y!^;CCQR94SFB^X'8S95*B>U>.M,-U6K+$[/6G4&I;%LNZ6#;-V7$DQ%
M.$O4U=*)1XY-%JA4F_<PXF+&9*7<X*MG&JD6PQLQE?BRNV\+1M2;?.<ES\YB
MA@R.1@HU8<=5$BR66J15;=M_B["QK5:21BHJS3HO0LW><DQF?R]RM'G!AH\)
M")99Z%":Y9EO63&T==;4EFK63X6!G-A8T 8V8H7;N%7IPF:PVY:1]C7.V8DW
MFYZX39]HE$/K6X/*FG29TC*,GL*5C!.7G9!QW.<YP^W[77F7&G4X<3D$9$A<
M,!RW+ ^.02?/'_$'QQ]-?SBJYW(U<G8R<,S+8M6);%A228IVEE:61)DYX=69
MV//AE/S(RL PN;ZQ[46]>=4[%KBW!)*&O=8(($0YE3@QP<P#DZ,=4GV_*,8,
MXIK.,X3@J/,PEUM/RK;23F&>,CGY74@_J.1R/^'(.O06S\\EV?$Y:IS')%>K
M>[%SRT4T<L?NPDC^)75O!X^>*12R@L5%_6J5N6+RV]M95W&5XUUU1ZZT$5>?
MX_ /;++<[VXRG/\ V<.DI<>RG&?XJQE7^/\ A/)YN3'G^&&)1^P8LW_/_GK>
M,239]7MWS'S^';2VWCU/^ZMNU=OE1^@+ MQ]SYUQ>=V]U*G>R&XX6DS.)>EU
M78=QK=9L+PR$/3(T9.F!FV <;!)(K+$Z>P0>$I6'B/M:X]#Z\.M*2F"D?I)(
ML9[#NWSD>6\_4?;CZ\<\^/.O$/J!EAD-TYB.M8:>A1R%RI2D("B5(IW26RJ!
MG4"S*C2H>>WL&%6\IXPCI[U(V[W@WE :GUR <1]<8(=?;P2,^5":_J&"$-RE
MIL!><H:3\ Z76H:,60R5/2OTL0!_.?\ >U^0PR6) B\GD\NWV4?<D_\ (?<^
M!KJ[+V;E]\9RMAL7$_5G1[]XHS5\=3[?FVK##A1PO(AB+*]B;I#'\S<C]'[5
M6M*IIK6E"U-1@LQU/US4H&FUP5>4K?3%5^.'C173'D(;P2>4@?ZJ1,4C#AAS
MQ!3OJZ\O.;.BJBJBCA54*/Z <#_Y_K^^OZ5XG%U,+C,?B*$?M4L;3KTJR$\L
M(:\:Q(7;@=Y&"]I'/S/(S.W+,3K/^?6I#3C33C33C33C33C33C33C33C34:+
MAW%ZST"^$:TM^VZ_"7 (Z-C)0)\6<?C(23ET-.1L;8;.'%$U:NR!;;[+C0,Y
M-1Y6&W6W%M)0M*LM->1N'MOU\T'9HNG;7ORZQ9IJ"_>6-B6*C>;*^3!_7DQ?
MW'Y*G69P=EK!XA V4$/-/)6A*LM8;=:6MIKR?[5N@$ZJCMWD[#&CM62MB&J@
MENF("UPHF)TR65",#& RT"%+QHV9)*F7922CQ(H=I*C"#6@DY(PTULZ:V12:
M];*!1I>=9%M.T56--#C$B2!6+#FIPO[Q6#+!P8A$:&F/ALX.]\D8&@I&<-!*
M)?S\7&FOXK&S*-<G[V/7+ .<YK*T'4R]9=&/CF:]9(V*C9L^/))DQ AR$"Q4
MO'F.G@NE1N&R/;@S+C+Z&FFM#U+O1U0O-V U_6-QPA]BF)1V$@77HFT1E9LL
MPT[EC,76+O*P0-+LA[K^,,"#0D^<Z>^MMD!)+BTIRTUE.XNV.@-!6"(JNV+X
MNL6"=AG;!%1C%2O%E?*AF35QKI^5U.M3K([*#4*'4DIUESW^W/L]BT*4TULC
M6&UM=;HJ(=[U=;8FZ50Y\D1J6B7'?:R:&I*2X\\,IH:0BY(7*V\D1TD((<PA
MUEQP=*'FE+::\Q_8M,&V'':I?FD-W^6J,G>XZO9"DE.$U2'EH^#DI?$@D-42
MV@:5E0!,B/'MGNY(PZR*XPVZZVTU\W/8M,U\Y3F;A-(AG+_=8C7512L*2,^\
M7.>%DC8F%1F.#+P&LL6(D7<&R&1(UG V4D&-+<92XTU]5<V72+9;K[0X"<0;
M;]8$P EZ@E@R@)<"Y:8K,U7G%JD A1SQ)>,2X2&?%/' N?$^SDC!##S2&FL$
M>[+Z0'ILQL%V],8ID#L9S4TE8$0=G=!3?FK -55PH7Q0BWI5C%A+9B\3L4T;
M7E$?-E$LIH8EQEIK+R=MZY"VG':4,M<>+M&7J#M\B:@2V8R;)U5B1+BGY*/+
M<%3%F.,F &X>C!SG)9H40B06"F/9<*2TUY%8VC0[E,[ K]<L+$A+:MFV:[?A
ME"20**[,$10\VT(07(AB!EIS%E,&**CB# VT+RAPA#J%MI::T55N\_5*ZWN-
MUQ6-P1,I9IN9<KL M$';1JQ8IYIQ3.8BN7HR 'I$^>Z\GX11XBPF+.>4AD'Z
MAU:49::EGQIIQIIQIIQIIQIIQIIQIIQIK\W?R$]9+9TW[?;3UT8 5&U]VT2=
MWU3+_"I <YK>S29DC620GLIPT4N*86]6)Q+>/B:G(:5$RC+2$975[$35YW7Z
M $LA_56^GU^O /!_<'7\T?4?:MK9V[\OBY8FCJO:FNXJ7J1'8QEJ5Y*K1L?#
M&%2:L_'A;$$J?0 F>7AYJEA[";XCJ_'PY9$-4K%1[A?7VTX5'1,-%21AQ!"W
M%+]66YQ$8J(9RM*E(/="'SE>7&E.\U=38FBX7^!U:0_8*/F)Y_0E2!SSY(_7
M5[]#*%O,;@EJ1Q/)4KSXZ]<<<%(8X996<MYY7WUC]H'@CO[:\\D ]-G6F&5-
M]\?)]<&'B&0B)'JGJL*6#RA+PTC4-$NV.=2$\ZV\RDP C8H&',.-.I:)8:^5
MI:<>U4Q$.;%MOL3"G/Z%8^3QX_O#Z?\ ]]3;8@,V_P#U2NAF"-)M+$I*G'99
M*> -F?HQ! =&R48/((#*.0?IJ,-0_9[O'Y7)1$E/8WALAK#WS/1=UV6(*"5G
M*LK6DAZ@U:CRRDN*SG+BFY1IU7KG/R8SGUYPKC:P/)]Q_P!F?Q_]H4__ %U5
MJ7_1V]/*LHDL?CN3'/)BO9-$1O/)#''U*$OG[\2@_OSJV_36B--]>J@S0]):
MVJ6LZHTYA]R*JL2Q'_<#,-I:^XS1V,+DIZ56TE#3DK-&'R3K:$(=*6E"<8[J
M1QQCK&BH/T4 <_N?N3^YY.M?PN PNW*:X_!XRGBZBGL8JD*Q^X_''N3R>9;$
MI' ,T[R2D  N0!K;//O4OIQIJ,5WU=V5G+5,RU+[4"T6KFD-N1%2<T13+2N%
M82,PTX.JP24\*=)Y=)0\5\Q [2T8?^#"<H:2K+36*_@SV]_.H%^FG7_]3<::
M?@SV]_.H%^FG7_\ 4W&FGX,]O?SJ!?IIU_\ U-QII^#/;W\Z@7Z:=?\ ]3<:
M:?@SV]_.H%^FG7_]3<::?@SV]_.H%^FG7_\ 4W&FMCZOU[OJK6-^2V9V)'VM
M7G(HD1BM-:>JU"4Q*.DAN#2^9J%F#RW<"CLF#9CU,88?R;A];B5C-I4TU5IO
M': ?7_:NY3^O>Z+E%[,M6SD6>P]/-FZ&G[17MU7DUZ"A2I;6UH17Q)B-C+()
M'BF@S$--2,>\Z&A[+H4?]!@=IK,>W5P.I/>K7UF<WL[UE25U(D(I^^YUH'MA
M@HLK;*#ETG,.9'R 3#QF!%2F)=MM+K2(+([:\-'J2MIK-.P<O [JZ?:>%?V(
MWV*BY3LSI&KVV[*H^:2/;QW=KACS IE/&"!8C!1H@UN(*P*PD<AAA1:G<N/N
MYPTUA-<I^U]0=V^H&@[2Q+6K5.NR]_S.B]H&N/F&.:\G]02H3&L[86M"L.6'
M6A<>U%!2+CV,RU8D(!SZ<5;/P<::R_%"ONP=,>4VD:^:+;N=MWOL@*N#(5D1
MZ;P]JW5^28<-]U3+656(%DZ!9=6Z@93IWL>>;:PXM+36&;U[ :2[%=7VNKVC
M:39R=X3H5(K%/TGC7MKKDWI*QP,M#JS+V>3.@@HBE1VO6@BE$3[,E\;[+64"
MN/!%&/,M-;7W+#]@_P"V]0DZ-F]>#WZ/Z5VMB5F=I0%BEJO,C#[:J&# F$5N
M4B"8Z:DYE,64P6\02,+'MR6%@OK6RMIIK9GCO;61JS8]CLQAV-S7+=MZL>_:
MT= C5=%)VK[(J#E*S$P8A)K&( >+A(DN(F\''.V-DM<L24@IYX !IK%-Y[9U
M_I/OCJ^[[0L&*K5".K.Q:XS-/1<U)"JG#MH4F0$CLIA8Z2?0\^'&'D(RME+6
M$#+]SB5*0E337L^QFPJAN&$Z27O6TOFU5,_O#J[(LP)'R@C:T14%M.+D''!I
M,((YAH4]AT9;I S3>5IPI"EMK;6IIK$>ZTK?NNNSH+L=J2MR5CF-N:]GNM%@
MAX@?#Z_Q#D&C9SKY<"1$^U#WVNU9F*[*'$YQAN(E! D+4XH5OC37J^S>FQ=(
M]"M6:AA$N23E-V+U[$E#AVWGGIJPO;5KLK;;"[CVJ>4Y-V(R6FB%N>JD9+5[
MU>B?7C37QV&T>7NKO.IF"F3*9L&E=/H*ZZCV(*V]G%/V3";QG<13Y6$)4S(P
MLF$8;!VF#(00S*5N5D&5#J>^G=:::T]IR&WANC4'DZARJ>7K[=U[L#T&14TD
M+:97:6-41<++1<%*/Y;:?AK4X$6/7Y/)"Q7(N9 )6<XRI12FFO9S';AL^-Z^
MT7K'.JK%QKDAK6E67J5,=;K1*72K+:F 8:WR!-H*'#CJ,-2ZR]*X7(H!+#,:
M'=*:E6OJG\,M-67;4H.\K7. ':O[ CZEA1XIL0Z">U)6-@*D)1)9;RY;$K-R
M\>2(EP1X0/[>TTMA&0\DX<RX2XE+36L/P9[>_G4"_33K_P#J;C33\&>WOYU
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7.--.--.--.--.--.--.--.--.--?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45656728908736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 23, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001332349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Brookdale Senior Living Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45656728838832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Oct. 23, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">54,968,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">6.26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 344,101,207.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 52,681.89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low prices of the Registrant&#8217;s common stock as reported on the New York Stock Exchange on October <div style="display:inline;">22</div>, 2024. </div> </td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45656728738080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 23, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 344,101,207.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">52,681.89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 52,681.89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M&7WPJFDSFHF197VU/TI#C4(]S*@U0V4WT'HBZ1T=)[9;:)N]]7]02P,$%
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MMN,OL+PHZ7\76"XN,[9FV:PU]7+># ,[L*SM!0&'R%5S^1$LQF%^!#",!U.
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M9Y:3;\[.\D#\GA.])Y_>!<E,'6.S2%,I:O!6SJB!H)V*V-NH);^ETC#84FJ
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M4$L! A0#%     @ .8176?L3^U4T @  8@4  !@              ("!8PX
M 'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( #F$5UDJQB!D
M"0,  !L0   -              "  <T0  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ .81769>*NQS     $P(   L              ( ! 10  %]R96QS
M+RYR96QS4$L! A0#%     @ .81765)Q;[5= 0  2 ,   \
M ( !ZA0  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( #F$5UF[;.KLN@
M !H#   :              "  706  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( #F$5UFF_$I;(P$  -\$   3              "
M 687  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     +  L R@(  +H8
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="d869187dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d869187dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d869187dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="d869187dexfilingfees.htm">d869187dexfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="17">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d869187dexfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "d869187dexfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 5,
    "http://xbrl.sec.gov/dei/2024": 1,
    "http://xbrl.sec.gov/ffd/2024q2": 4
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 17,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P10_23_2024To10_23_2024",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d869187dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P10_23_2024To10_23_2024",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d869187dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis",
      "name": "ffd:FeesOthrRuleFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d869187dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis",
      "name": "ffd:FeesOthrRuleFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d869187dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "P10_23_2024To10_23_2024",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d869187dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P10_23_2024To10_23_2024",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d869187dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-24-241886-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-241886-xbrl.zip
M4$L#!!0    ( #F$5UE_M'&P30P  #&2   8    9#@V.3$X-V1E>&9I;&EN
M9V9E97,N:'1M[1UK4]NZ\OOY%1KW]+2=P?$C+T@@9RB%<YE#@8%TIO=3Q[&5
M1(-CNY(,R?WU=R7;B9,X(0DA&' _4-M:[Z[VH5TITOKP[^' 1?>8,N)[1Y^,
MDOX)8<_V'>+UCCX=WYZ<GW_ZN_7'89\#&(!ZK-&Y<XZ4/N=!0],>'AY*'4K]
M.\=R<<GV!YJIFQ5#-\M*#.T2[VX*?-BA;LFG/8#4RYIH[E@,)^"BU2'C%]+
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M/F^VP5L8NL0/Z,8?6%[TL(E2+"+)Q4Q*(C$]1'+K^*XS%L]8.G$L!LIU%.M
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M$4#V^<!M_1]02P$"% ,4    "  YA%=9?[1QL$T,   QD@  &
M    @ $     9#@V.3$X-V1E>&9I;&EN9V9E97,N:'1M4$L%!@     !  $
*1@   (,,      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d869187dexfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="P10_23_2024To10_23_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001332349</identifier>
        </entity>
        <period>
            <startDate>2024-10-23</startDate>
            <endDate>2024-10-23</endDate>
        </period>
    </context>
    <context id="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001332349</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-23</startDate>
            <endDate>2024-10-23</endDate>
        </period>
    </context>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_shares">
        <measure>shares</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="P10_23_2024To10_23_2024" id="ixv-325">0001332349</dei:EntityCentralIndexKey>
    <ffd:SubmissnTp contextRef="P10_23_2024To10_23_2024" id="ixv-326">424B7</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="P10_23_2024To10_23_2024" id="ixv-327">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:PrevslyPdFlg
      contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis"
      id="hidden123221170">false</ffd:PrevslyPdFlg>
    <ffd:TtlPrevslyPdAmt
      contextRef="P10_23_2024To10_23_2024"
      decimals="0"
      id="ixv-329"
      unitRef="Unit_USD">0</ffd:TtlPrevslyPdAmt>
    <ffd:FormTp contextRef="P10_23_2024To10_23_2024" id="ixv-354">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="P10_23_2024To10_23_2024" id="ixv-355">Brookdale Senior Living Inc.</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp
      contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis"
      id="ixv-356">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis"
      id="ixv-357">Common Stock, $0.01 par value per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg
      contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis"
      id="ixv-358">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-359"
      unitRef="Unit_shares">54968244</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis"
      decimals="2"
      id="ixv-360"
      unitRef="Unit_pure">6.26</ffd:MaxOfferingPricPerScty>
    <ffd:TtlOfferingAmt
      contextRef="P10_23_2024To10_23_2024"
      decimals="2"
      id="ixv-361"
      unitRef="Unit_USD">344101207.44</ffd:TtlOfferingAmt>
    <ffd:MaxAggtOfferingPric
      contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis"
      decimals="2"
      id="ixv-362"
      unitRef="Unit_USD">344101207.44</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis"
      decimals="INF"
      id="ixv-363"
      unitRef="Unit_pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis"
      decimals="2"
      id="ixv-364"
      unitRef="Unit_USD">52681.89</ffd:FeeAmt>
    <ffd:TtlFeeAmt
      contextRef="P10_23_2024To10_23_2024"
      decimals="2"
      id="ixv-365"
      unitRef="Unit_USD">52681.89</ffd:TtlFeeAmt>
    <ffd:NetFeeAmt
      contextRef="P10_23_2024To10_23_2024"
      decimals="2"
      id="ixv-366"
      unitRef="Unit_USD">52681.89</ffd:NetFeeAmt>
    <ffd:OfferingNote
      contextRef="P10_23_2024To10_23_2024_1TypedMemberffdOfferingAxis"
      id="ixv-316">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low prices of the Registrant&#x2019;s common stock as reported on the New York Stock Exchange on October &lt;div style="display:inline;"&gt;22&lt;/div&gt;, 2024. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
